SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Brighthouse Life Insurance Co of NY – ‘10-Q’ for 6/30/19

On:  Thursday, 8/8/19, at 4:03pm ET   ·   For:  6/30/19   ·   Accession #:  1167609-19-11   ·   File #:  0-55705

Previous ‘10-Q’:  ‘10-Q’ on 5/9/19 for 3/31/19   ·   Next:  ‘10-Q’ on 11/6/19 for 9/30/19   ·   Latest:  ‘10-Q’ on 8/9/22 for 6/30/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/08/19  Brighthouse Life Ins Co of NY     10-Q        6/30/19   87:15M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.83M 
 2: EX-10.1     Material Contract                                   HTML    173K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     28K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     28K 
13: R1          Document and Entity Information                     HTML     74K 
14: R2          Consolidated Balance Sheets (Unaudited)             HTML    112K 
15: R3          Consolidated Balance Sheets (Unaudited)             HTML     41K 
                (Parenthetical)                                                  
16: R4          Consolidated Statements of Operations and           HTML     74K 
                Comprehensive Income (Unaudited)                                 
17: R5          Consolidated Statements of Stockholders' Equity     HTML     44K 
                (Unaudited)                                                      
18: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML     78K 
19: R7          Business, Basis of Presentation and Summary of      HTML     47K 
                Significant Accounting Policies                                  
20: R8          Segment Information                                 HTML    210K 
21: R9          Insurance                                           HTML     63K 
22: R10         Investments                                         HTML    408K 
23: R11         Derivatives                                         HTML    282K 
24: R12         Fair Value                                          HTML    455K 
25: R13         Equity                                              HTML    169K 
26: R14         Other Revenues and Other Expenses                   HTML     64K 
27: R15         Contingencies, Commitments and Guarantees           HTML     43K 
28: R16         Related Party Transactions                          HTML     96K 
29: R17         Business, Basis of Presentation and Summary of      HTML     76K 
                Significant Accounting Policies (Policies)                       
30: R18         Segment Information (Tables)                        HTML    199K 
31: R19         Insurance (Tables)                                  HTML     61K 
32: R20         Investments (Tables)                                HTML    395K 
33: R21         Derivatives (Tables)                                HTML    464K 
34: R22         Fair Value (Tables)                                 HTML    439K 
35: R23         Equity (Tables)                                     HTML    169K 
36: R24         Other Revenues and Other Expenses Other Revenues    HTML     56K 
                and Other Expenses (Tables)                                      
37: R25         Related Party Transactions (Tables)                 HTML     60K 
38: R26         Business, Basis of Presentation and Summary of      HTML     31K 
                Significant Accounting Policies (Narrative)                      
                (Details)                                                        
39: R27         Segment Information (Operating Results) (Details)   HTML     71K 
40: R28         Segment Information (Reconciliation of Operating    HTML     39K 
                Revenues to Total Revenues) (Details)                            
41: R29         Segment Information (Total Assets) (Details)        HTML     35K 
42: R30         Segment Information (Narrative) (Details)           HTML     26K 
43: R31         Insurance (Guarantees Related to Annuity            HTML     43K 
                Contracts) (Details)                                             
44: R32         Investments (Fixed Maturity Securities AFS by       HTML     66K 
                Sector) (Details)                                                
45: R33         Investments (Maturities of Fixed Maturity           HTML     61K 
                Securities) (Details)                                            
46: R34         Investments (Continuous Gross Unrealized Losses     HTML     70K 
                for Fixed Maturity Securities AFS by Sector)                     
                (Details)                                                        
47: R35         Investments (Mortgage Loans by Portfolio Segment)   HTML     45K 
                (Details)                                                        
48: R36         Investments (Credit Quality of Mortgage Loans)      HTML     64K 
                (Details)                                                        
49: R37         Investments (Net Unrealized Investment Gains        HTML     38K 
                (Losses)) (Details)                                              
50: R38         Investments (Changes in Net Unrealized Investment   HTML     37K 
                Gains (Losses)) (Details)                                        
51: R39         Investments (Invested Assets on Deposit and         HTML     31K 
                Pledged as Collateral) (Details)                                 
52: R40         Investments (Variable Interest Entities) (Details)  HTML     31K 
53: R41         Investments (Net Investment Income) (Details)       HTML     43K 
54: R42         Investments (Components of Net Investment Gains     HTML     37K 
                (Losses)) (Details)                                              
55: R43         Investments (Sales or Disposals of Fixed Maturity   HTML     36K 
                Securities) (Details)                                            
56: R44         Investments (Fixed Maturity Securities AFS -        HTML     30K 
                Narrative) (Details)                                             
57: R45         Investments (Continuous Gross Unrealized Losses     HTML     40K 
                for Fixed Maturity Securities AFS by Sector -                    
                Narrative) (Details)                                             
58: R46         Investments (Mortgage Loans - Narrative) (Details)  HTML     45K 
59: R47         Investments (Cash Equivalents - Narrative)          HTML     27K 
                (Details)                                                        
60: R48         Investments (Invested Assets on Deposit and         HTML     30K 
                Pledged as Collateral - Narrative) (Details)                     
61: R49         Investments (Variable Interest Entities -           HTML     27K 
                Narrative) (Details)                                             
62: R50         Investments (Net Investment Income & Net            HTML     29K 
                Investment Gains (Losses) - Narrative) (Details)                 
63: R51         Investments (Related Party Investment Transactions  HTML     30K 
                - Narrative) (Details)                                           
64: R52         Derivatives (Primary Risks Managed by Derivatives)  HTML     64K 
                (Details)                                                        
65: R53         Derivatives Derivatives (NQ, CF, FV) Details        HTML     76K 
                (Details)                                                        
66: R54         Derivatives (Derivatives (Estimated Fair Value of   HTML     67K 
                Derivative Assets and Liabilities after Master                   
                Netting Agreements and Cash Collateral) (Details)                
67: R55         Derivatives (Estimated Fair Value of OTC-Bilateral  HTML     32K 
                Derivatives (Details)                                            
68: R56         Derivatives (NQ, FV, CF - Narrative) (Details)      HTML     29K 
69: R57         Fair Value (Recurring Fair Value Measurements)      HTML    135K 
                (Details)                                                        
70: R58         Fair Value (Assets and Liabilities Measured -       HTML     50K 
                Quantitative Information) (Details)                              
71: R59         Fair Value (Unobservable Input Reconciliation)      HTML    106K 
                (Details)                                                        
72: R60         Fair Value (Financial Instruments Carried at Other  HTML     52K 
                Than Fair Value) (Details)                                       
73: R61         Equity (Capital Transactions) (Details)             HTML     27K 
74: R62         Equity (Components of Accumulated Other             HTML     60K 
                Comprehensive Income (Loss)) (Details)                           
75: R63         Equity (Reclassifications Out of Accumulated Other  HTML     60K 
                Comprehensive Income (Loss)) (Details)                           
76: R64         Other Expenses (Other Expenses) (Details)           HTML     43K 
77: R65         Other Revenues and Other Expenses Other Revenues    HTML     29K 
                (Narrative) (Details)                                            
78: R66         Contingencies, Commitments and Guarantees           HTML     34K 
                (Commitments and Guarantees - Narrative) (Details)               
79: R67         Related Party Transactions (Effects of Affiliated   HTML     43K 
                Reinsurance on Statements of Operations) (Details)               
80: R68         Related Party Transactions (Effects of Affiliated   HTML     35K 
                Reinsurance on Balance Sheets) (Details)                         
81: R69         Related Party Transactions (Reinsurance             HTML     32K 
                Transactions - Narrative) (Details)                              
82: R70         Related Party Transactions (Shared Services and     HTML     39K 
                Overhead Allocations - Narrative) (Details)                      
83: R71         Related Party Transactions (Broker Dealer           HTML     35K 
                Transactions - Narrative) (Details)                              
85: XML         IDEA XML File -- Filing Summary                      XML    167K 
12: XML         XBRL Instance -- bhny-20190630x10q_htm               XML   5.58M 
84: EXCEL       IDEA Workbook of Financial Reports                  XLSX    107K 
 8: EX-101.CAL  XBRL Calculations -- bhny-20190630_cal               XML    156K 
 9: EX-101.DEF  XBRL Definitions -- bhny-20190630_def                XML    696K 
10: EX-101.LAB  XBRL Labels -- bhny-20190630_lab                     XML   1.55M 
11: EX-101.PRE  XBRL Presentations -- bhny-20190630_pre              XML    996K 
 7: EX-101.SCH  XBRL Schema -- bhny-20190630                         XSD    165K 
86: JSON        XBRL Instance as JSON Data -- MetaLinks              338±   549K 
87: ZIP         XBRL Zipped Folder -- 0001167609-19-000011-xbrl      Zip    430K 


‘10-Q’   —   Quarterly Report
Document Table of Contents

Page (sequential)   (alphabetic) Top
 
11st Page  –  Filing Submission
"Table of Contents
"Part I -- Financial Information
"Interim Condensed Balance Sheets
"Interim Condensed Statements of Operations and Comprehensive Income (Loss)
"Interim Condensed Statements of Stockholder's Equity
"Interim Condensed Statements of Cash Flows
"Notes to the Interim Condensed Financial Statements (Unaudited)
"Note 1 -- Business, Basis of Presentation and Summary of Significant Accounting Policies
"Note 2 -- Segment Information
"Note 3 -- Insurance
"Note 4 -- Investments
"Note 5 -- Derivatives
"Note 6 -- Fair Value
"Note 7 -- Equity
"Note 8 -- Other Revenues and Other Expenses
"Note 9 -- Contingencies, Commitments and Guarantees
"Note 10 -- Related Party Transactions
"Management's Discussion and Analysis of Financial Condition and Results of Operations
"Introduction
"Overview
"Summary of Critical Accounting Estimates
"Non-GAAP and Other Financial Disclosures
"Results of Operations
"Note Regarding Forward-Looking Statements
"Controls and Procedures
"Part II -- Other Information
"Legal Proceedings
"Risk Factors
"Exhibits
"Signatures

This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C:   C: 
  Document  
 i 1 i 1 i 0 i false i --12-31 i Q2 i 2019 i 0001167609 i BRIGHTHOUSE LIFE INSURANCE Co OF NY i 0 i 10 i 10 i 200000 i 200000 i 200000 i 200000 i 200000 i 200000 i 0 i 0 i 0 i 0 i 0 i 0 i 0 i 0 i 0 i 0 i 0 i 0 0001167609 2019-01-01 2019-06-30 0001167609 2019-08-08 0001167609 2018-12-31 0001167609 2019-06-30 0001167609 2018-01-01 2018-06-30 0001167609 2019-04-01 2019-06-30 0001167609 2018-04-01 2018-06-30 0001167609 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-03-31 0001167609 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001167609 us-gaap:CommonStockMember 2018-06-30 0001167609 2017-12-31 0001167609 us-gaap:RetainedEarningsMember 2017-12-31 0001167609 2018-06-30 0001167609 us-gaap:RetainedEarningsMember 2018-03-31 0001167609 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 2018-03-31 0001167609 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-30 0001167609 2018-01-01 2018-03-31 0001167609 us-gaap:CommonStockMember 2018-03-31 0001167609 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001167609 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2017-12-31 0001167609 2018-03-31 0001167609 us-gaap:CommonStockMember 2017-12-31 0001167609 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001167609 us-gaap:RetainedEarningsMember 2018-06-30 0001167609 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-04-01 2018-06-30 0001167609 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0001167609 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001167609 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-31 0001167609 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-01-01 2019-03-31 0001167609 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-03-31 0001167609 us-gaap:RetainedEarningsMember 2018-12-31 0001167609 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001167609 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001167609 2019-03-31 0001167609 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001167609 2019-01-01 2019-03-31 0001167609 us-gaap:RetainedEarningsMember 2019-06-30 0001167609 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001167609 us-gaap:RetainedEarningsMember 2019-03-31 0001167609 us-gaap:CommonStockMember 2019-06-30 0001167609 us-gaap:CommonStockMember 2018-12-31 0001167609 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001167609 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001167609 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-06-30 0001167609 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-04-01 2019-06-30 0001167609 us-gaap:CommonStockMember 2019-03-31 0001167609 us-gaap:SpinoffMember 2017-08-04 0001167609 us-gaap:CorporateAndOtherMember 2018-01-01 2018-06-30 0001167609 us-gaap:OperatingSegmentsMember bhny:LifeMember 2018-01-01 2018-06-30 0001167609 us-gaap:OperatingSegmentsMember bhny:AnnuitiesMember 2018-01-01 2018-06-30 0001167609 us-gaap:OperatingSegmentsMember 2018-01-01 2018-06-30 0001167609 us-gaap:OperatingSegmentsMember us-gaap:CorporateAndOtherMember 2018-01-01 2018-06-30 0001167609 us-gaap:MaterialReconcilingItemsMember 2018-01-01 2018-06-30 0001167609 bhny:LifeMember 2018-01-01 2018-06-30 0001167609 bhny:AnnuitiesMember 2018-01-01 2018-06-30 0001167609 bhny:LifeMember 2018-04-01 2018-06-30 0001167609 us-gaap:OperatingSegmentsMember us-gaap:CorporateAndOtherMember 2018-04-01 2018-06-30 0001167609 us-gaap:OperatingSegmentsMember bhny:LifeMember 2018-04-01 2018-06-30 0001167609 us-gaap:OperatingSegmentsMember bhny:AnnuitiesMember 2018-04-01 2018-06-30 0001167609 us-gaap:MaterialReconcilingItemsMember 2018-04-01 2018-06-30 0001167609 us-gaap:OperatingSegmentsMember 2018-04-01 2018-06-30 0001167609 bhny:AnnuitiesMember 2018-04-01 2018-06-30 0001167609 us-gaap:CorporateAndOtherMember 2018-04-01 2018-06-30 0001167609 us-gaap:OperatingSegmentsMember us-gaap:CorporateAndOtherMember 2019-01-01 2019-06-30 0001167609 us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-06-30 0001167609 us-gaap:OperatingSegmentsMember bhny:AnnuitiesMember 2019-01-01 2019-06-30 0001167609 us-gaap:OperatingSegmentsMember bhny:LifeMember 2019-01-01 2019-06-30 0001167609 us-gaap:OperatingSegmentsMember 2019-01-01 2019-06-30 0001167609 us-gaap:CorporateAndOtherMember 2019-01-01 2019-06-30 0001167609 bhny:LifeMember 2019-01-01 2019-06-30 0001167609 bhny:AnnuitiesMember 2019-01-01 2019-06-30 0001167609 bhny:AnnuitiesMember 2019-04-01 2019-06-30 0001167609 us-gaap:OperatingSegmentsMember us-gaap:CorporateAndOtherMember 2019-04-01 2019-06-30 0001167609 bhny:LifeMember 2019-04-01 2019-06-30 0001167609 us-gaap:OperatingSegmentsMember 2019-04-01 2019-06-30 0001167609 us-gaap:OperatingSegmentsMember bhny:LifeMember 2019-04-01 2019-06-30 0001167609 us-gaap:OperatingSegmentsMember bhny:AnnuitiesMember 2019-04-01 2019-06-30 0001167609 us-gaap:MaterialReconcilingItemsMember 2019-04-01 2019-06-30 0001167609 us-gaap:CorporateAndOtherMember 2019-04-01 2019-06-30 0001167609 bhny:LifeMember 2018-12-31 0001167609 bhny:AnnuitiesMember 2019-06-30 0001167609 us-gaap:CorporateAndOtherMember 2019-06-30 0001167609 us-gaap:CorporateAndOtherMember 2018-12-31 0001167609 bhny:AnnuitiesMember 2018-12-31 0001167609 bhny:LifeMember 2019-06-30 0001167609 us-gaap:VariableAnnuityMember us-gaap:AnnuitizationBenefitMember 2018-12-31 0001167609 us-gaap:VariableAnnuityMember us-gaap:AnnuitizationBenefitMember 2018-01-01 2018-12-31 0001167609 us-gaap:VariableAnnuityMember us-gaap:GuaranteedMinimumDeathBenefitMember 2019-01-01 2019-06-30 0001167609 us-gaap:VariableAnnuityMember us-gaap:GuaranteedMinimumDeathBenefitMember 2018-12-31 0001167609 us-gaap:VariableAnnuityMember us-gaap:GuaranteedMinimumDeathBenefitMember 2019-06-30 0001167609 us-gaap:VariableAnnuityMember us-gaap:AnnuitizationBenefitMember 2019-01-01 2019-06-30 0001167609 us-gaap:VariableAnnuityMember us-gaap:AnnuitizationBenefitMember 2019-06-30 0001167609 us-gaap:VariableAnnuityMember us-gaap:GuaranteedMinimumDeathBenefitMember 2018-01-01 2018-12-31 0001167609 us-gaap:USTreasuryAndGovernmentMember 2019-06-30 0001167609 us-gaap:DomesticCorporateDebtSecuritiesMember 2019-06-30 0001167609 us-gaap:USStatesAndPoliticalSubdivisionsMember 2018-12-31 0001167609 us-gaap:AssetBackedSecuritiesMember 2019-06-30 0001167609 us-gaap:DomesticCorporateDebtSecuritiesMember 2018-12-31 0001167609 us-gaap:ForeignCorporateDebtSecuritiesMember 2018-12-31 0001167609 us-gaap:ForeignGovernmentDebtSecuritiesMember 2018-12-31 0001167609 us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0001167609 us-gaap:CommercialMortgageBackedSecuritiesMember 2019-06-30 0001167609 us-gaap:ResidentialMortgageBackedSecuritiesMember 2018-12-31 0001167609 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-06-30 0001167609 us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-06-30 0001167609 us-gaap:CommercialMortgageBackedSecuritiesMember 2018-12-31 0001167609 us-gaap:ForeignCorporateDebtSecuritiesMember 2019-06-30 0001167609 us-gaap:AssetBackedSecuritiesMember 2018-12-31 0001167609 us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-06-30 0001167609 bhny:NonIncomeProducingDebtSecuritiesMember 2019-06-30 0001167609 bhny:NonIncomeProducingDebtSecuritiesMember 2018-12-31 0001167609 bhny:SixMonthsOrGreaterMember bhny:TwentyPercentOrMoreMember us-gaap:DebtSecuritiesMember 2019-06-30 0001167609 us-gaap:DebtSecuritiesMember 2019-01-01 2019-06-30 0001167609 us-gaap:DebtSecuritiesMember 2019-06-30 0001167609 us-gaap:DebtSecuritiesMember 2018-12-31 0001167609 bhny:DscGreaterThan120PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember 2018-12-31 0001167609 us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember 2019-06-30 0001167609 bhny:DscGreaterThan120PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv65To75PercentMember 2018-12-31 0001167609 bhny:DscLessThan100PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv76To80PercentMember 2019-06-30 0001167609 bhny:Dsc100To120PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv65To75PercentMember 2018-12-31 0001167609 bhny:Dsc100To120PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:LtvLessThan65PercentMember 2019-06-30 0001167609 bhny:DscLessThan100PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv65To75PercentMember 2019-06-30 0001167609 bhny:DscLessThan100PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv65To75PercentMember 2018-12-31 0001167609 us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv76To80PercentMember 2019-06-30 0001167609 bhny:DscGreaterThan120PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:LtvLessThan65PercentMember 2018-12-31 0001167609 bhny:DscLessThan100PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:LtvLessThan65PercentMember 2018-12-31 0001167609 bhny:Dsc100To120PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember 2018-12-31 0001167609 bhny:Dsc100To120PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:LtvLessThan65PercentMember 2018-12-31 0001167609 us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv65To75PercentMember 2019-06-30 0001167609 bhny:Dsc100To120PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember 2019-06-30 0001167609 bhny:DscGreaterThan120PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv65To75PercentMember 2019-06-30 0001167609 us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:LtvLessThan65PercentMember 2019-06-30 0001167609 bhny:DscLessThan100PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv76To80PercentMember 2018-12-31 0001167609 bhny:DscLessThan100PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember 2018-12-31 0001167609 us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv65To75PercentMember 2018-12-31 0001167609 bhny:DscGreaterThan120PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:LtvLessThan65PercentMember 2019-06-30 0001167609 bhny:Dsc100To120PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv76To80PercentMember 2019-06-30 0001167609 us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:LtvLessThan65PercentMember 2018-12-31 0001167609 bhny:Dsc100To120PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv65To75PercentMember 2019-06-30 0001167609 bhny:DscLessThan100PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:LtvLessThan65PercentMember 2019-06-30 0001167609 us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember 2018-12-31 0001167609 bhny:Dsc100To120PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv76To80PercentMember 2018-12-31 0001167609 bhny:DscGreaterThan120PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember 2019-06-30 0001167609 bhny:DscGreaterThan120PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv76To80PercentMember 2018-12-31 0001167609 us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv76To80PercentMember 2018-12-31 0001167609 bhny:DscLessThan100PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember 2019-06-30 0001167609 bhny:DscGreaterThan120PercentMember us-gaap:CommercialPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv76To80PercentMember 2019-06-30 0001167609 us-gaap:RealEstateLoanMember 2019-04-01 2019-06-30 0001167609 bhny:AgriculturalPortfolioSegmentMember us-gaap:RealEstateLoanMember 2018-12-31 0001167609 bhny:AgriculturalPortfolioSegmentMember us-gaap:RealEstateLoanMember 2019-06-30 0001167609 bhny:AgriculturalPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv65To75PercentMember 2019-06-30 0001167609 bhny:AgriculturalPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:LtvLessThan65PercentMember 2019-06-30 0001167609 bhny:AgriculturalPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:Ltv65To75PercentMember 2018-12-31 0001167609 bhny:AgriculturalPortfolioSegmentMember us-gaap:RealEstateLoanMember bhny:LtvLessThan65PercentMember 2018-12-31 0001167609 us-gaap:RealEstateLoanMember 2018-04-01 2018-06-30 0001167609 us-gaap:RealEstateLoanMember 2018-01-01 2018-06-30 0001167609 us-gaap:PerformingFinancingReceivableMember us-gaap:RealEstateLoanMember 2018-12-31 0001167609 us-gaap:RealEstateLoanMember 2019-01-01 2019-06-30 0001167609 us-gaap:PerformingFinancingReceivableMember us-gaap:RealEstateLoanMember 2019-06-30 0001167609 us-gaap:CashAndCashEquivalentsMember 2019-04-01 2019-06-30 0001167609 us-gaap:CashAndCashEquivalentsMember 2018-01-01 2018-06-30 0001167609 us-gaap:OtherInvestmentsMember 2019-04-01 2019-06-30 0001167609 us-gaap:MortgagesMember 2019-01-01 2019-06-30 0001167609 us-gaap:DebtSecuritiesMember 2019-04-01 2019-06-30 0001167609 us-gaap:MortgagesMember 2018-01-01 2018-06-30 0001167609 us-gaap:DebtSecuritiesMember 2018-01-01 2018-06-30 0001167609 us-gaap:MortgagesMember 2018-04-01 2018-06-30 0001167609 us-gaap:OtherInvestmentsMember 2019-01-01 2019-06-30 0001167609 us-gaap:CashAndCashEquivalentsMember 2019-01-01 2019-06-30 0001167609 us-gaap:DebtSecuritiesMember 2018-04-01 2018-06-30 0001167609 us-gaap:OtherInvestmentsMember 2018-04-01 2018-06-30 0001167609 us-gaap:MortgagesMember 2019-04-01 2019-06-30 0001167609 us-gaap:DebtSecuritiesMember 2019-01-01 2019-06-30 0001167609 us-gaap:CashAndCashEquivalentsMember 2018-04-01 2018-06-30 0001167609 us-gaap:OtherInvestmentsMember 2018-01-01 2018-06-30 0001167609 us-gaap:DebtSecuritiesMember 2018-01-01 2018-06-30 0001167609 us-gaap:DebtSecuritiesMember 2018-04-01 2018-06-30 0001167609 us-gaap:DebtSecuritiesMember 2019-04-01 2019-06-30 0001167609 bhny:MetlifeInvestmentAdvisorsLLCMember 2018-04-01 2018-06-30 0001167609 bhny:MetlifeInvestmentAdvisorsLLCMember 2018-01-01 2018-06-30 0001167609 us-gaap:StockOptionMember us-gaap:NondesignatedMember 2019-06-30 0001167609 us-gaap:InterestRateCapMember us-gaap:NondesignatedMember 2018-12-31 0001167609 us-gaap:NondesignatedMember 2019-06-30 0001167609 bhny:CededGuaranteedMinimumBenefitMember 2019-06-30 0001167609 us-gaap:StockOptionMember us-gaap:NondesignatedMember 2018-12-31 0001167609 bhny:DirectGuaranteedMinimumBenefitMember 2019-06-30 0001167609 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001167609 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember 2018-12-31 0001167609 bhny:CededGuaranteedMinimumBenefitMember 2018-12-31 0001167609 us-gaap:NondesignatedMember 2018-12-31 0001167609 bhny:DirectindexlinkedannuitiesMember 2018-12-31 0001167609 us-gaap:InterestRateCapMember us-gaap:NondesignatedMember 2019-06-30 0001167609 bhny:DirectindexlinkedannuitiesMember 2019-06-30 0001167609 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember 2019-06-30 0001167609 bhny:DirectGuaranteedMinimumBenefitMember 2018-12-31 0001167609 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001167609 us-gaap:NondesignatedMember 2019-01-01 2019-06-30 0001167609 us-gaap:InvestmentIncomeMember 2019-01-01 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2018-01-01 2018-06-30 0001167609 us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2019-01-01 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:InvestmentIncomeMember 2019-01-01 2019-06-30 0001167609 us-gaap:CashFlowHedgingMember 2019-01-01 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2018-01-01 2018-06-30 0001167609 bhny:NetDerivativeGainLossMember 2018-01-01 2018-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-01-01 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2019-01-01 2019-06-30 0001167609 us-gaap:CashFlowHedgingMember bhny:NetDerivativeGainLossMember 2019-01-01 2019-06-30 0001167609 us-gaap:EquityContractMember us-gaap:NondesignatedMember 2019-01-01 2019-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2018-01-01 2018-06-30 0001167609 us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2018-01-01 2018-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-01-01 2018-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2018-01-01 2018-06-30 0001167609 us-gaap:InvestmentIncomeMember 2018-01-01 2018-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember bhny:NetDerivativeGainLossMember 2018-01-01 2018-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:NondesignatedMember 2019-01-01 2019-06-30 0001167609 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2019-01-01 2019-06-30 0001167609 us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2019-01-01 2019-06-30 0001167609 bhny:NetDerivativeGainLossMember 2019-01-01 2019-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2019-01-01 2019-06-30 0001167609 us-gaap:NondesignatedMember 2018-01-01 2018-06-30 0001167609 us-gaap:EquityContractMember us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2019-01-01 2019-06-30 0001167609 us-gaap:CashFlowHedgingMember us-gaap:InvestmentIncomeMember 2019-01-01 2019-06-30 0001167609 us-gaap:CashFlowHedgingMember bhny:NetDerivativeGainLossMember 2018-01-01 2018-06-30 0001167609 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2019-01-01 2019-06-30 0001167609 us-gaap:CashFlowHedgingMember 2018-01-01 2018-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2018-01-01 2018-06-30 0001167609 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2018-01-01 2018-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:NondesignatedMember 2018-01-01 2018-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2019-01-01 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2019-01-01 2019-06-30 0001167609 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2019-01-01 2019-06-30 0001167609 us-gaap:EquityContractMember us-gaap:NondesignatedMember 2018-01-01 2018-06-30 0001167609 us-gaap:CashFlowHedgingMember us-gaap:InvestmentIncomeMember 2018-01-01 2018-06-30 0001167609 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2018-01-01 2018-06-30 0001167609 us-gaap:EquityContractMember us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2018-01-01 2018-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2019-01-01 2019-06-30 0001167609 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2018-01-01 2018-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember bhny:NetDerivativeGainLossMember 2019-01-01 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:InvestmentIncomeMember 2018-01-01 2018-06-30 0001167609 us-gaap:EquityContractMember us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2019-01-01 2019-06-30 0001167609 us-gaap:EquityContractMember us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2018-01-01 2018-06-30 0001167609 us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2018-01-01 2018-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2018-04-01 2018-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2019-04-01 2019-06-30 0001167609 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2018-04-01 2018-06-30 0001167609 us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2018-04-01 2018-06-30 0001167609 us-gaap:InvestmentIncomeMember 2018-04-01 2018-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2019-04-01 2019-06-30 0001167609 us-gaap:CashFlowHedgingMember us-gaap:InvestmentIncomeMember 2019-04-01 2019-06-30 0001167609 us-gaap:EquityContractMember us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2019-04-01 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2019-04-01 2019-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2018-04-01 2018-06-30 0001167609 us-gaap:CashFlowHedgingMember 2018-04-01 2018-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:NondesignatedMember 2019-04-01 2019-06-30 0001167609 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2019-04-01 2019-06-30 0001167609 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2019-04-01 2019-06-30 0001167609 bhny:NetDerivativeGainLossMember 2019-04-01 2019-06-30 0001167609 us-gaap:EquityContractMember us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2018-04-01 2018-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember bhny:NetDerivativeGainLossMember 2018-04-01 2018-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2018-04-01 2018-06-30 0001167609 us-gaap:EquityContractMember us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2019-04-01 2019-06-30 0001167609 us-gaap:CashFlowHedgingMember bhny:NetDerivativeGainLossMember 2019-04-01 2019-06-30 0001167609 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2018-04-01 2018-06-30 0001167609 us-gaap:CashFlowHedgingMember 2019-04-01 2019-06-30 0001167609 us-gaap:NondesignatedMember 2019-04-01 2019-06-30 0001167609 us-gaap:EquityContractMember us-gaap:NondesignatedMember 2019-04-01 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:InvestmentIncomeMember 2018-04-01 2018-06-30 0001167609 us-gaap:CashFlowHedgingMember us-gaap:InvestmentIncomeMember 2018-04-01 2018-06-30 0001167609 us-gaap:NondesignatedMember 2018-04-01 2018-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2018-04-01 2018-06-30 0001167609 us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2019-04-01 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-04-01 2018-06-30 0001167609 us-gaap:EquityContractMember us-gaap:NondesignatedMember 2018-04-01 2018-06-30 0001167609 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2019-04-01 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2018-04-01 2018-06-30 0001167609 us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2018-04-01 2018-06-30 0001167609 us-gaap:CashFlowHedgingMember bhny:NetDerivativeGainLossMember 2018-04-01 2018-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:NondesignatedMember 2018-04-01 2018-06-30 0001167609 us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2019-04-01 2019-06-30 0001167609 us-gaap:EquityContractMember us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2018-04-01 2018-06-30 0001167609 bhny:NetDerivativeGainLossMember 2018-04-01 2018-06-30 0001167609 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2018-04-01 2018-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember bhny:NetDerivativeGainLossMember 2019-04-01 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember bhny:NetDerivativeGainLossMember 2019-04-01 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-04-01 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:InvestmentIncomeMember 2019-04-01 2019-06-30 0001167609 us-gaap:InvestmentIncomeMember 2019-04-01 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:InvestmentIncomeMember 2019-04-01 2019-06-30 0001167609 us-gaap:FixedMaturitiesMember 2018-12-31 0001167609 us-gaap:FixedMaturitiesMember 2019-06-30 0001167609 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ForeignCorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ForeignCorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:DomesticCorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:DomesticCorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ForeignCorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:EquityContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:DomesticCorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:DomesticCorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ForeignCorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:EquityContractMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:ForeignCorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:DomesticCorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:ForeignCorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:DomesticCorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:DomesticCorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:DomesticCorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:ForeignCorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:ForeignCorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001167609 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputLapseRateMember 2019-06-30 0001167609 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEntityCreditRiskMember 2018-12-31 0001167609 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEntityCreditRiskMember 2018-12-31 0001167609 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputLapseRateMember 2018-12-31 0001167609 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputMortalityRateMember 2019-06-30 0001167609 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputMortalityRateMember 2018-12-31 0001167609 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputMortalityRateMember 2019-06-30 0001167609 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputMortalityRateMember 2018-12-31 0001167609 srt:MinimumMember us-gaap:FairValueInputsLevel3Member bhny:MeasurementInputLongTermEquityVolatilitiesMember 2019-06-30 0001167609 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputUtilizationRateMember 2018-12-31 0001167609 srt:MaximumMember us-gaap:FairValueInputsLevel3Member bhny:MeasurementInputLongTermEquityVolatilitiesMember 2018-12-31 0001167609 srt:MaximumMember us-gaap:FairValueInputsLevel3Member bhny:MeasurementInputLongTermEquityVolatilitiesMember 2019-06-30 0001167609 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputWithdrawalRateMember 2018-12-31 0001167609 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEntityCreditRiskMember 2019-06-30 0001167609 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputUtilizationRateMember 2018-12-31 0001167609 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputWithdrawalRateMember 2018-12-31 0001167609 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputWithdrawalRateMember 2019-06-30 0001167609 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputUtilizationRateMember 2019-06-30 0001167609 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEntityCreditRiskMember 2019-06-30 0001167609 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputUtilizationRateMember 2019-06-30 0001167609 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputWithdrawalRateMember 2019-06-30 0001167609 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputLapseRateMember 2018-12-31 0001167609 srt:MinimumMember us-gaap:FairValueInputsLevel3Member bhny:MeasurementInputLongTermEquityVolatilitiesMember 2018-12-31 0001167609 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputLapseRateMember 2019-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2018-01-01 2018-06-30 0001167609 bhny:StructuredSecuritiesMember 2019-01-01 2019-06-30 0001167609 bhny:StructuredSecuritiesMember 2018-12-31 0001167609 us-gaap:CorporateDebtSecuritiesMember 2017-12-31 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2019-01-01 2019-06-30 0001167609 bhny:StructuredSecuritiesMember 2018-01-01 2018-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2018-06-30 0001167609 bhny:NetDerivativesMember 2018-01-01 2018-06-30 0001167609 bhny:NetDerivativesMember 2019-01-01 2019-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2017-12-31 0001167609 bhny:NetDerivativesMember 2018-06-30 0001167609 us-gaap:CorporateDebtSecuritiesMember 2019-01-01 2019-06-30 0001167609 us-gaap:CorporateDebtSecuritiesMember 2018-01-01 2018-06-30 0001167609 bhny:StructuredSecuritiesMember 2017-12-31 0001167609 us-gaap:CorporateDebtSecuritiesMember 2019-06-30 0001167609 bhny:NetDerivativesMember 2019-06-30 0001167609 bhny:StructuredSecuritiesMember 2019-06-30 0001167609 bhny:NetDerivativesMember 2018-12-31 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2018-12-31 0001167609 us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001167609 bhny:StructuredSecuritiesMember 2018-06-30 0001167609 us-gaap:CorporateDebtSecuritiesMember 2018-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2019-06-30 0001167609 bhny:NetDerivativesMember 2017-12-31 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2019-04-01 2019-06-30 0001167609 bhny:StructuredSecuritiesMember 2018-04-01 2018-06-30 0001167609 bhny:StructuredSecuritiesMember 2019-04-01 2019-06-30 0001167609 us-gaap:CorporateDebtSecuritiesMember 2019-04-01 2019-06-30 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2018-04-01 2018-06-30 0001167609 bhny:StructuredSecuritiesMember 2019-03-31 0001167609 bhny:NetDerivativesMember 2018-04-01 2018-06-30 0001167609 bhny:NetDerivativesMember 2018-03-31 0001167609 us-gaap:CorporateDebtSecuritiesMember 2018-04-01 2018-06-30 0001167609 bhny:StructuredSecuritiesMember 2018-03-31 0001167609 bhny:NetDerivativesMember 2019-04-01 2019-06-30 0001167609 us-gaap:CorporateDebtSecuritiesMember 2019-03-31 0001167609 us-gaap:CorporateDebtSecuritiesMember 2018-03-31 0001167609 bhny:NetDerivativesMember 2019-03-31 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2019-03-31 0001167609 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2018-03-31 0001167609 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-06-30 0001167609 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-06-30 0001167609 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-06-30 0001167609 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-06-30 0001167609 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-06-30 0001167609 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0001167609 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0001167609 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0001167609 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0001167609 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-31 0001167609 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0001167609 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-06-30 0001167609 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-06-30 0001167609 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-12-31 0001167609 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-06-30 0001167609 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-06-30 0001167609 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-04-01 2019-06-30 0001167609 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-04-01 2019-06-30 0001167609 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-03-31 0001167609 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-03-31 0001167609 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-01-01 2018-06-30 0001167609 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-06-30 0001167609 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-06-30 0001167609 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0001167609 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2017-12-31 0001167609 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-06-30 0001167609 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-04-01 2018-06-30 0001167609 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-03-31 0001167609 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-04-01 2018-06-30 0001167609 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-03-31 0001167609 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-04-01 2019-06-30 0001167609 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-04-01 2019-06-30 0001167609 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-04-01 2018-06-30 0001167609 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-06-30 0001167609 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-04-01 2018-06-30 0001167609 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-06-30 0001167609 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001167609 us-gaap:CurrencySwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-06-30 0001167609 us-gaap:CurrencySwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-04-01 2018-06-30 0001167609 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-06-30 0001167609 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-06-30 0001167609 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-04-01 2018-06-30 0001167609 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-06-30 0001167609 us-gaap:CurrencySwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-04-01 2019-06-30 0001167609 us-gaap:CurrencySwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-06-30 0001167609 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-06-30 0001167609 us-gaap:DistributionServiceMember 2019-04-01 2019-06-30 0001167609 us-gaap:DistributionServiceMember 2019-01-01 2019-06-30 0001167609 us-gaap:DistributionServiceMember 2018-01-01 2018-06-30 0001167609 us-gaap:DistributionServiceMember 2018-04-01 2018-06-30 0001167609 us-gaap:LoanOriginationCommitmentsMember 2018-12-31 0001167609 us-gaap:CommitmentsToExtendCreditMember 2019-06-30 0001167609 us-gaap:CommitmentsToExtendCreditMember 2018-12-31 0001167609 us-gaap:LoanOriginationCommitmentsMember 2019-06-30 0001167609 bhny:CededReinsuranceMember srt:AffiliatedEntityMember 2018-04-01 2018-06-30 0001167609 bhny:CededReinsuranceMember srt:AffiliatedEntityMember 2019-04-01 2019-06-30 0001167609 bhny:CededReinsuranceMember srt:AffiliatedEntityMember 2018-01-01 2018-06-30 0001167609 bhny:CededReinsuranceMember srt:AffiliatedEntityMember 2019-01-01 2019-06-30 0001167609 bhny:CededGuaranteedMinimumBenefitMember srt:AffiliatedEntityMember 2018-01-01 2018-06-30 0001167609 bhny:CededGuaranteedMinimumBenefitMember srt:AffiliatedEntityMember 2018-04-01 2018-06-30 0001167609 bhny:CededGuaranteedMinimumBenefitMember srt:AffiliatedEntityMember 2018-12-31 0001167609 bhny:CededGuaranteedMinimumBenefitMember srt:AffiliatedEntityMember 2019-04-01 2019-06-30 0001167609 bhny:CededGuaranteedMinimumBenefitMember srt:AffiliatedEntityMember 2019-01-01 2019-06-30 0001167609 bhny:CededGuaranteedMinimumBenefitMember srt:AffiliatedEntityMember 2019-06-30 0001167609 bhny:CededReinsuranceMember srt:AffiliatedEntityMember 2018-12-31 0001167609 bhny:CededReinsuranceMember srt:AffiliatedEntityMember 2019-06-30 0001167609 bhny:AllServicesandTransactionsExceptBrokerDealerActivitiesMember 2018-12-31 0001167609 srt:AffiliatedEntityMember 2019-04-01 2019-06-30 0001167609 srt:AffiliatedEntityMember 2018-04-01 2018-06-30 0001167609 bhny:AllServicesandTransactionsExceptBrokerDealerActivitiesMember 2019-06-30 0001167609 srt:AffiliatedEntityMember 2018-01-01 2018-06-30 0001167609 srt:AffiliatedEntityMember 2019-01-01 2019-06-30 0001167609 bhny:BrokerDealerActivitiesMember 2019-04-01 2019-06-30 0001167609 bhny:BrokerDealerActivitiesMember 2018-12-31 0001167609 bhny:BrokerDealerActivitiesMember 2018-04-01 2018-06-30 0001167609 bhny:BrokerDealerActivitiesMember 2018-01-01 2018-06-30 0001167609 bhny:BrokerDealerActivitiesMember 2019-01-01 2019-06-30 0001167609 bhny:BrokerDealerActivitiesMember 2019-06-30 iso4217:USD xbrli:shares xbrli:shares xbrli:pure bhny:segment iso4217:USD bhny:Contracts
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM  i 10-Q
 i 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended  i June 30, 2019
or
 i 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___ to ___                
Commission File Number:  i 000-55705
 
bhflogorgb970pxa38.jpg
Brighthouse Life Insurance Company of NY
(Exact name of registrant as specified in its charter)
 i New York
 
 i 13-3690700
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
 
 
 
 
 
 
 
 
 i 285 Madison Avenue, 14th Floor,
 i New York,
 i New York
 
 
 i 10017
(Address of principal executive offices)
 
(Zip Code)
( i 980)  i 365-7100
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act: None
Title of each class
Trading symbol(s)
Name of each exchange on which registered
 
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     i Yes þ    No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     i Yes þ    No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
¨
 
Accelerated filer
¨
 
 i Non-accelerated filer
þ
 
Smaller reporting company
 i 
 
 
Emerging growth company
 i 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  i     No þ
As of August 8, 2019,  i 200,000 shares of the registrant’s common stock were outstanding, all of which were owned indirectly by Brighthouse Financial, Inc.
REDUCED DISCLOSURE FORMAT
The registrant meets the conditions set forth in General Instruction H(1)(a) and (b) of Form 10-Q and is, therefore, filing this Form 10-Q with the reduced disclosure format.
 
 


Table of Contents

Table of Contents
 
Page
 
Item 1.
Financial Statements (at June 30, 2019 (Unaudited) and December 31, 2018 and for the Three Months and Six Months Ended June 30, 2019 and 2018 (Unaudited)):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 2.
Item 4.
 
 
 
 
Item 1.
Item 1A.
Item 6.
 
 
 


Table of Contents

Part I — Financial Information
Item 1. Financial Statements
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Interim Condensed Balance Sheets
June 30, 2019 (Unaudited) and December 31, 2018
(In thousands, except share and per share data)
 
 
 
Assets
 
 
 
 
Investments:
 
 
 
 
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $2,694,974 and $2,469,801, respectively)
 
$
 i 2,817,791

 
$
 i 2,433,633

Mortgage loans (net of valuation allowances of $2,142 and $1,937, respectively)
 
 i 520,644

 
 i 448,105

Other invested assets, principally at estimated fair value
 
 i 50,145

 
 i 35,815

Total investments
 
 i 3,388,580

 
 i 2,917,553

Cash and cash equivalents
 
 i 190,199

 
 i 120,130

Accrued investment income
 
 i 38,702

 
 i 20,605

Premiums, reinsurance and other receivables
 
 i 628,838

 
 i 580,480

Deferred policy acquisition costs and value of business acquired
 
 i 172,674

 
 i 185,586

Other assets
 
 i 34,012

 
 i 37,348

Separate account assets
 
 i 4,612,744

 
 i 4,268,423

Total assets
 
$
 i 9,065,749

 
$
 i 8,130,125

Liabilities and Stockholder's Equity
 
 
 
 
Liabilities
 
 
 
 
Future policy benefits
 
$
 i 732,751

 
$
 i 718,599

Policyholder account balances
 
 i 1,979,117

 
 i 1,692,498

Other policy-related balances
 
 i 18,638

 
 i 9,288

Payables for collateral under derivative transactions
 
 i 39,671

 
 i 23,581

Current income tax payable
 
 i 1,854

 
 i 1,755

Deferred income tax liability
 
 i 139,196

 
 i 107,853

Other liabilities
 
 i 505,893

 
 i 471,490

Separate account liabilities
 
 i 4,612,744

 
 i 4,268,423

Total liabilities
 
 i 8,029,864

 
 i 7,293,487

Contingencies, Commitments and Guarantees (Note 9)
 
 i 
 
 i 
Stockholder's Equity
 
 
 
 
Common stock, par value $10 per share; 200,000 shares authorized, issued and outstanding
 
 i 2,000

 
 i 2,000

Additional paid-in capital
 
 i 490,931

 
 i 415,931

Retained earnings (deficit)
 
 i 451,254

 
 i 433,778

Accumulated other comprehensive income (loss)
 
 i 91,700

 
( i 15,071
)
Total stockholder's equity
 
 i 1,035,885

 
 i 836,638

Total liabilities and stockholder's equity
 
$
 i 9,065,749

 
$
 i 8,130,125

See accompanying notes to the interim condensed financial statements.

2

Table of Contents

Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Interim Condensed Statements of Operations and Comprehensive Income (Loss)
For the Three Months and Six Months Ended June 30, 2019 and 2018 (Unaudited)
(In thousands)
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2019
 
2018
 
2019
 
2018
Revenues
 
 
 
 
 
 
 
Premiums
$
 i 6,966

 
$
 i 9,112

 
$
 i 15,998

 
$
 i 19,405

Universal life and investment-type product policy fees
 i 24,143

 
 i 25,883

 
 i 47,393

 
 i 51,869

Net investment income
 i 29,716

 
 i 24,089

 
 i 56,209

 
 i 48,020

Other revenues
( i 21,708
)
 
( i 12,076
)
 
( i 42,031
)
 
( i 24,620
)
Net investment gains (losses)
 i 5,472

 
( i 2,063
)
 
 i 5,020

 
( i 4,418
)
Net derivative gains (losses)
 i 27,308

 
( i 21,112
)
 
 i 24,063

 
( i 65,374
)
Total revenues
 i 71,897

 
 i 23,833

 
 i 106,652

 
 i 24,882

Expenses
 
 
 
 
 
 
 
Policyholder benefits and claims
 i 14,388

 
 i 3,948

 
 i 23,847

 
 i 2,407

Interest credited to policyholder account balances
 i 9,133

 
 i 9,337

 
 i 17,391

 
 i 18,569

Amortization of deferred policy acquisition costs and value of business acquired
 i 5,560

 
 i 1,495

 
 i 6,463

 
( i 1,828
)
Other expenses
 i 19,624

 
 i 16,181

 
 i 38,514

 
 i 31,908

Total expenses
 i 48,705

 
 i 30,961

 
 i 86,215

 
 i 51,056

Income (loss) before provision for income tax
 i 23,192

 
( i 7,128
)
 
 i 20,437

 
( i 26,174
)
Provision for income tax expense (benefit)
 i 4,205

 
( i 2,167
)
 
 i 2,961

 
( i 6,843
)
Net income (loss)
$
 i 18,987

 
$
( i 4,961
)
 
$
 i 17,476

 
$
( i 19,331
)
Comprehensive income (loss)
$
 i 79,838

 
$
( i 20,089
)
 
$
 i 124,247

 
$
( i 64,749
)
See accompanying notes to the interim condensed financial statements.

3

Table of Contents

Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Interim Condensed Statements of Stockholder’s Equity
For the Six Months Ended June 30, 2019 and 2018 (Unaudited)
(In thousands)
 
Common
Stock
 
Additional
Paid-in
Capital
 
Retained
Earnings
(Deficit)
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Total
Stockholders
Equity
$
 i 2,000

 
$
 i 415,931

 
$
 i 433,778

 
$
( i 15,071
)
 
$
 i 836,638

Net income (loss)

 

 
( i 1,511
)
 

 
( i 1,511
)
Capital contribution
 
 
 i 75,000

 
 
 
 
 
 i 75,000

Other comprehensive income (loss), net of income tax


 


 


 
 i 45,920

 
 i 45,920

Balance at March 31, 2019
 i 2,000

 
 i 490,931

 
 i 432,267

 
 i 30,849

 
 i 956,047

Net income (loss)
 
 
 
 
 i 18,987

 
 
 
 i 18,987

Other comprehensive income (loss), net of income tax
 
 
 
 
 
 
 i 60,851

 
 i 60,851

Balance at June 30, 2019
$
 i 2,000

 
$
 i 490,931

 
$
 i 451,254

 
$
 i 91,700

 
$
 i 1,035,885

 
Common
Stock
 
Additional
Paid-in
Capital
 
Retained
Earnings
(Deficit)
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Total
Stockholders
Equity
$
 i 2,000

 
$
 i 415,931

 
$
 i 395,928

 
$
 i 29,628

 
$
 i 843,487

Net income (loss)
 
 
 
 
( i 14,370
)
 
 
 
( i 14,370
)
Other comprehensive income (loss), net of income tax
 
 
 
 
 
 
( i 30,290
)
 
( i 30,290
)
Balance at March 31, 2018
 i 2,000

 
 i 415,931

 
 i 381,558

 
( i 662
)
 
 i 798,827

Net income (loss)
 
 
 
 
( i 4,961
)
 
 
 
( i 4,961
)
Other comprehensive income (loss), net of income tax
 
 
 
 
 
 
( i 15,128
)
 
( i 15,128
)
Balance at June 30, 2018
$
 i 2,000

 
$
 i 415,931

 
$
 i 376,597

 
$
( i 15,790
)
 
$
 i 778,738


See accompanying notes to the interim condensed financial statements.

4

Table of Contents

Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Interim Condensed Statements of Cash Flows
For the Six Months Ended June 30, 2019 and 2018 (Unaudited)
(In thousands)
 
Six Months Ended 
 June 30,
 
2019
 
2018
Net cash provided by (used in) operating activities
$
( i 3,696
)
 
$
 i 55,004

Cash flows from investing activities
 
 
 
Sales, maturities and repayments of:
 
 
 
Fixed maturity securities
 i 460,751

 
 i 183,586

Mortgage loans
 i 6,735

 
 i 8,376

Purchases of:
 
 
 
Fixed maturity securities
( i 662,395
)
 
( i 306,386
)
Mortgage loans
( i 81,578
)
 
( i 23,922
)
Cash received in connection with freestanding derivatives
 i 49,501

 
 i 3,121

Cash paid in connection with freestanding derivatives
( i 8,125
)
 
( i 36,550
)
Net change in short-term investments
 i 

 
( i 32,913
)
Net change in other invested assets
 i 6,326

 
 i 372

Net cash provided by (used in) investing activities
( i 228,785
)
 
( i 204,316
)
Cash flows from financing activities
 
 
 
Policyholder account balances:
 
 
 
Deposits
 i 299,212

 
 i 219,081

Withdrawals
( i 87,752
)
 
( i 61,144
)
Net change in payables for collateral under derivative transactions
 i 16,090

 
 i 21,621

Capital contribution
 i 75,000

 
 i 

Net cash provided by (used in) financing activities
 i 302,550

 
 i 179,558

Change in cash, cash equivalents and restricted cash
 i 70,069

 
 i 30,246

Cash, cash equivalents and restricted cash, beginning of period
 i 120,130

 
 i 86,154

Cash, cash equivalents and restricted cash, end of period
$
 i 190,199

 
$
 i 116,400

Supplemental disclosures of cash flow information
 
 
 
Net cash paid (received) for:
 
 
 
Income tax
$
 i 

 
$
 i 8


See accompanying notes to the interim condensed financial statements.

5

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited)

 i 
1. Business, Basis of Presentation and Summary of Significant Accounting Policies
Business
“BHNY” and the “Company” refer to Brighthouse Life Insurance Company of NY, a New York domiciled life insurance company. Brighthouse Life Insurance Company of NY is a wholly-owned subsidiary of Brighthouse Life Insurance Company, which is an indirect wholly-owned subsidiary of Brighthouse Financial, Inc. (“BHF” together with its subsidiaries and affiliates, “Brighthouse Financial”). The Company is licensed to transact business in the state of New York.
BHNY markets and/or administers traditional life, universal life, variable annuity and fixed annuity products to individuals. The Company is organized into  i two segments: Annuities; and Life. In addition, the Company reports certain of its results of operations in Corporate & Other.
In 2016, MetLife, Inc. (together with its subsidiaries and affiliates, “MetLife”) announced its plan to pursue the separation of a substantial portion of its former U.S. retail business (the “Separation”). In connection with the Separation,  i 80.8% of MetLife, Inc.’s interest in BHF was distributed to holders of MetLife, Inc.’s common stock. On June 14, 2018, MetLife, Inc. divested its remaining shares of BHF common stock (the “MetLife Divestiture”). As a result, MetLife, Inc. and its subsidiaries and affiliates are no longer considered related parties subsequent to the MetLife Divestiture.
 i 
Basis of Presentation
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the interim condensed financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from these estimates.
 i 
Reclassifications
Certain amounts in the prior year periods’ interim condensed financial statements and related footnotes thereto have been reclassified to conform with the 2019 presentation as may be discussed throughout the Notes to the Interim Condensed Financial Statements.
Since the Company is a member of a controlled group of affiliated companies, its results may not be indicative of those of a stand-alone entity.
The accompanying interim condensed financial statements are unaudited and reflect all adjustments (including normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in conformity with GAAP. Interim results are not necessarily indicative of full year performance. The December 31, 2018 balance sheet data was derived from audited financial statements included in BHNY’s Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Annual Report”), which include all disclosures required by GAAP. Therefore, these interim condensed financial statements should be read in conjunction with the financial statements of the Company included in the 2018 Annual Report.
 i 
Adoption of New Accounting Pronouncements
Changes to GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates (“ASUs”) to the FASB Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. ASUs not listed below were assessed and determined to be either not applicable or are not expected to have a material impact on the Company’s financial statements. There were no ASUs adopted during 2019 which had a material impact on the Company’s financial statements.

6

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

ASUs issued but not yet adopted as of June 30, 2019 are summarized in the table below.
Standard
Description
Effective Date
Impact on Financial Statements
ASU 2018-12, Financial Services-Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts
The amendments to Topic 944 will result in significant changes to the accounting for long-duration insurance contracts. These changes (1) require all guarantees that qualify as market risk benefits to be measured at fair value, (2) require more frequent updating of assumptions and modify existing discount rate requirements for certain insurance liabilities, (3) modify the methods of amortization for deferred acquisition costs (“DAC”), and (4) require new qualitative and quantitative disclosures around insurance contract asset and liability balances and the judgments, assumptions and methods used to measure those balances. The market risk benefit guidance is required to be applied on a retrospective basis, while the changes to guidance for insurance liabilities and DAC may be applied to existing carrying amounts on the effective date or on a retrospective basis.
The amendments are currently effective on January 1, 2021. On July 17, 2019 the FASB tentatively decided to extend the effective date of the ASU by one year. The FASB intends to release an exposure draft, which if adopted, will change the effective date for the Company to January 1, 2022.
The Company is in the early stages of evaluating the new guidance and therefore is unable to estimate the impact to its financial statements. The most significant impact will be the measurement of liabilities for variable annuity guarantees.
ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments
The amendments to Topic 326 replace the incurred loss impairment methodology for certain financial instruments with one that reflects expected credit losses based on historical loss information, current conditions, and reasonable and supportable forecasts. The new guidance also requires that an other-than- temporary impairment (“OTTI”) on a debt security will be recognized as an allowance going forward, such that improvements in expected future cash flows after an impairment will no longer be reflected as a prospective yield adjustment through net investment income, but rather a reversal of the previous impairment and recognized through realized investment gains and losses.
January 1, 2020 using the modified retrospective method (with early adoption permitted beginning January 1, 2019)
The Company is currently evaluating the impact of this guidance on its financial statements, with the most significant impact expected to be earlier recognition of credit losses on mortgage loan investments.



7

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

 i 
2. Segment Information
The Company is organized into  i two segments: Annuities and Life. In addition, the Company reports certain of its results of operations in Corporate & Other.
Annuities
The Annuities segment consists of a variety of variable, fixed, index-linked and income annuities designed to address contract holders’ needs for protected wealth accumulation on a tax-deferred basis, wealth transfer and income security.
Life
The Life segment consists of insurance products and services, including term, whole and universal life products designed to address policyholders’ needs for financial security and protected wealth transfer, which may be provided on a tax-advantaged basis.
Corporate & Other
Corporate & Other contains the excess capital not allocated to the segments and expenses associated with certain legal proceedings and income tax audit issues. Corporate & Other also includes the elimination of intersegment amounts and a portion of MetLife’s former U.S. insurance business sold direct to consumers, which is no longer being offered for new sales.
Financial Measures and Segment Accounting Policies
Adjusted earnings is a financial measure used by management to evaluate performance, allocate resources and facilitate comparisons to industry results. Consistent with GAAP guidance for segment reporting, adjusted earnings is also used to measure segment performance. The Company believes the presentation of adjusted earnings, as the Company measures it for management purposes, enhances the understanding of its performance by highlighting the results of operations and the underlying profitability drivers of the business. Adjusted earnings should not be viewed as a substitute for net income (loss).
Adjusted earnings, which may be positive or negative, focuses on the Company’s primary businesses principally by excluding the impact of market volatility, which could distort trends.
The following are significant items excluded from total revenues, net of income tax, in calculating adjusted earnings:
Net investment gains (losses);
Net derivative gains (losses) except earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment; and
Certain variable annuity guaranteed minimum income benefits (“GMIBs”) fees (“GMIB Fees”) and amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses).
The following are significant items excluded from total expenses, net of income tax, in calculating adjusted earnings:
Amounts associated with benefits and hedging costs related to GMIBs (“GMIB Costs”);
Amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”); and
Amortization of DAC and value of business acquired related to: (i) net investment gains (losses), (ii) net derivative gains (losses), (iii) GMIB Fees and GMIB Costs and (iv) Market Value Adjustments.
The tax impact of the adjustments mentioned above is calculated net of the statutory tax rate, which could differ from the Company’s effective tax rate.
Set forth in the tables below is certain financial information with respect to the Company’s segments, as well as Corporate & Other, for the three months and six months ended June 30, 2019 and 2018 and at June 30, 2019 and December 31, 2018. The segment accounting policies are the same as those used to prepare the Company’s condensed financial statements, except for the adjustments to calculate adjusted earnings described above. In addition, segment accounting policies include the methods of capital allocation described below.

8

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
2. Segment Information (continued)

Segment investment and capitalization targets are based on statutory oriented risk principles and metrics. Segment invested assets backing liabilities are based on net statutory liabilities plus excess capital. For the variable annuity business, the excess capital held is based on the target statutory total asset requirement consistent with the Company’s variable annuity risk management strategy. For insurance businesses other than variable annuities, excess capital held is based on a percentage of required statutory risk-based capital. Assets in excess of those allocated to the segments, if any, are held in Corporate & Other. Segment net investment income reflects the performance of each segment’s respective invested assets.
 i 
 
 
Operating Results
Three Months Ended June 30, 2019
 
Annuities
 
Life
 
Corporate & Other
 
Total
 
 
(In thousands)
Pre-tax adjusted earnings
 
$
( i 6,972
)
 
$
( i 5,928
)
 
$
( i 1,149
)
 
$
( i 14,049
)
Provision for income tax expense (benefit)
 
( i 1,886
)
 
( i 1,244
)
 
( i 485
)
 
( i 3,615
)
Adjusted earnings
 
$
( i 5,086
)
 
$
( i 4,684
)
 
$
( i 664
)
 
( i 10,434
)
Adjustments for:
 
 
 
 
 
 
 
 
Net investment gains (losses)
 
 
 
 
 
 
 
 i 5,472

Net derivative gains (losses)
 
 
 
 
 
 
 
 i 27,308

Other adjustments to net income
 
 
 
 
 
 
 
 i 4,461

Provision for income tax (expense) benefit
 
 
 
 
 
 
 
( i 7,820
)
Net income (loss)
 
 
 
 
 
 
 
$
 i 18,987

 
 
 
 
 
 
 
 
 
Interest revenue
 
$
 i 20,107

 
$
 i 9,306

 
$
 i 398

 
 
 
 
Operating Results
Three Months Ended June 30, 2018
 
Annuities
 
Life
 
Corporate & Other
 
Total
 
 
(In thousands)
Pre-tax adjusted earnings
 
$
 i 6,473

 
$
 i 4,556

 
$
 i 186

 
$
 i 11,215

Provision for income tax expense (benefit)
 
 i 880

 
 i 959

 
( i 154
)
 
 i 1,685

Adjusted earnings
 
$
 i 5,593

 
$
 i 3,597

 
$
 i 340

 
 i 9,530

Adjustments for:
 
 
 
 
 
 
 
 
Net investment gains (losses)
 
 
 
 
 
 
 
( i 2,063
)
Net derivative gains (losses)
 
 
 
 
 
 
 
( i 21,112
)
Other adjustments to net income
 
 
 
 
 
 
 
 i 4,832

Provision for income tax (expense) benefit
 
 
 
 
 
 
 
 i 3,852

Net income (loss)
 
 
 
 
 
 
 
$
( i 4,961
)
 
 
 
 
 
 
 
 
 
Interest revenue
 
$
 i 15,278

 
$
 i 8,482

 
$
 i 425

 
 
 / 

9

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
2. Segment Information (continued)

 
 
Operating Results
Six Months Ended June 30, 2019
 
Annuities
 
Life
 
Corporate & Other
 
Total
 
 
(In thousands)
Pre-tax adjusted earnings
 
$
( i 11,951
)
 
$
( i 10,184
)
 
$
( i 1,702
)
 
$
( i 23,837
)
Provision for income tax expense (benefit)
 
( i 3,354
)
 
( i 2,138
)
 
( i 844
)
 
( i 6,336
)
Adjusted earnings
 
$
( i 8,597
)
 
$
( i 8,046
)
 
$
( i 858
)
 
( i 17,501
)
Adjustments for:
 
 
 
 
 
 
 
 
Net investment gains (losses)
 
 
 
 
 
 
 
 i 5,020

Net derivative gains (losses)
 
 
 
 
 
 
 
 i 24,063

Other adjustments to net income
 
 
 
 
 
 
 
 i 15,191

Provision for income tax (expense) benefit
 
 
 
 
 
 
 
( i 9,297
)
Net income (loss)
 
 
 
 
 
 
 
$
 i 17,476

 
 
 
 
 
 
 
 
 
Interest revenue
 
$
 i 37,879

 
$
 i 17,610

 
$
 i 907

 
 

 
 
Operating Results
Six Months Ended June 30, 2018
 
Annuities
 
Life
 
Corporate & Other
 
Total
 
 
(In thousands)
Pre-tax adjusted earnings
 
$
 i 11,903

 
$
 i 12,570

 
$
 i 2,448

 
$
 i 26,921

Provision for income tax expense (benefit)
 
 i 1,537

 
 i 2,642

 
 i 127

 
 i 4,306

Adjusted earnings
 
$
 i 10,366

 
$
 i 9,928

 
$
 i 2,321

 
 i 22,615

Adjustments for:
 
 
 
 
 
 
 
 
Net investment gains (losses)
 
 
 
 
 
 
 
( i 4,418
)
Net derivative gains (losses)
 
 
 
 
 
 
 
( i 65,374
)
Other adjustments to net income
 
 
 
 
 
 
 
 i 16,697

Provision for income tax (expense) benefit
 
 
 
 
 
 
 
 i 11,149

Net income (loss)
 
 
 
 
 
 
 
$
( i 19,331
)
 
 
 
 
 
 
 
 
 
Interest revenue
 
$
 i 30,081

 
$
 i 17,321

 
$
 i 796

 
 

 i 
The following table presents total revenues with respect to the Company’s segments, as well as Corporate & Other:
 
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
 
2019
 
2018
 
2019
 
2018
 
 
(In thousands)
Annuities
 
$
 i 21,820

 
$
 i 28,106

 
$
 i 43,707

 
$
 i 55,744

Life
 
 i 13,477

 
 i 14,407

 
 i 26,124

 
 i 30,103

Corporate & Other
 
 i 528

 
 i 1,079

 
 i 1,198

 
 i 2,103

Adjustments
 
 i 36,072

 
( i 19,759
)
 
 i 35,623

 
( i 63,068
)
Total
 
$
 i 71,897

 
$
 i 23,833

 
$
 i 106,652

 
$
 i 24,882


 / 

10

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
2. Segment Information (continued)

The following table presents total assets with respect to the Company’s segments, as well as Corporate & Other, at:



(In thousands)
Annuities
$
 i 7,828,964


$
 i 7,034,394

Life
 i 1,157,104


 i 1,083,641

Corporate & Other
 i 79,681


 i 12,090

Total
$
 i 9,065,749


$
 i 8,130,125


 i 
3. Insurance
Guarantees
As discussed in Notes 1 and 3 of the Notes to the Financial Statements included in the 2018 Annual Report, the Company issues variable annuity contracts with guaranteed minimum benefits. Guaranteed minimum accumulation benefits (“GMABs”), the non-life contingent portion of guaranteed minimum withdrawal benefits (“GMWBs”) and certain portions of GMIBs that do not require the policyholder to annuitize are accounted for as embedded derivatives in policyholder account balances and are further discussed in Note 5.
 i 
Information regarding the Company’s guarantee exposure was as follows at:
 
 
 
 
 
 
In the
Event of Death
 
At
Annuitization
 
In the
Event of Death
 
At
Annuitization
 
 
 
(Dollars in thousands)
 
Annuity Contracts (1), (2)
 
 
 
 
 
 
 
 
 
Variable Annuity Guarantees
 
 
 
 
 
 
 
 
 
Total account value (3)
 
$
 i 4,618,740

 
$
 i 3,732,716

 
$
 i 4,274,326

 
$
 i 3,483,668

 
Separate account value
 
$
 i 4,610,504

 
$
 i 3,732,340

 
$
 i 4,266,520

 
$
 i 3,482,829

 
Net amount at risk
 
$
 i 6,893

(4)
$
 i 230,389

(5)
$
 i 193,102

(4)
$
 i 274,632

(5)
Average attained age of contract holders
 
 i 68 years

 
 i 68 years

 
 i 67 years

 
 i 67 years

 
______________
(1)
The Company’s annuity contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive.
(2)
Includes direct business, but excludes offsets from hedging or reinsurance, if any. Therefore, the net amount at risk presented reflects the economic exposures of living and death benefit guarantees associated with variable annuities, but not necessarily their impact on the Company. See Note 5 of the Notes to the Financial Statements included in the 2018 Annual Report for a discussion of guaranteed minimum benefits which have been reinsured.
(3)
Includes the contract holder’s investments in the general account and separate account, if applicable.
(4)
Defined as the death benefit less the total account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death.
 / 
(5)
Defined as the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company’s potential economic exposure to such guarantees in the event all contract holders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contract holders have achieved.

11

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

 i 
4. Investments
See Note 1 of the Notes to the Financial Statements included in the 2018 Annual Report for a description of the Company’s accounting policies for investments and Note 6 for information about the fair value hierarchy for investments and the related valuation methodologies.
Fixed Maturity Securities Available-for-sale (“AFS”)
Fixed Maturity Securities AFS by Sector
 i 
The following table presents the fixed maturity securities AFS by sector at:
 
 
 
Amortized
Cost
 
Gross Unrealized
 
Estimated
Fair
Value
 
Amortized
Cost
 
Gross Unrealized
 
Estimated
Fair
Value
 
Gains
 
Temporary
Losses
 
OTTI
Losses
 
Gains
 
Temporary
Losses
 
OTTI
Losses
 
 
(In thousands)
Fixed maturity securities: (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. corporate
$
 i 1,251,600

 
$
 i 57,287

 
$
 i 2,807

 
$
 i 

 
$
 i 1,306,080

 
$
 i 890,676

 
$
 i 5,402

 
$
 i 23,034

 
$
 i 

 
$
 i 873,044

U.S. government and agency
 i 299,264

 
 i 22,155

 
 i 23

 
 i 

 
 i 321,396

 
 i 511,255

 
 i 9,961

 
 i 13,697

 
 i 

 
 i 507,519

Foreign corporate
 i 395,861

 
 i 14,648

 
 i 4,493

 
 i 

 
 i 406,016

 
 i 368,149

 
 i 1,473

 
 i 17,258

 
 i 

 
 i 352,364

CMBS
 i 279,986

 
 i 15,213

 
 i 139

 
 i 

 
 i 295,060

 
 i 325,491

 
 i 1,481

 
 i 4,121

 
 i 

 
 i 322,851

RMBS
 i 306,421


 i 11,692


 i 1,162


 i 


 i 316,951


 i 200,827


 i 4,643


 i 2,882


 i 


 i 202,588

ABS
 i 75,917

 
 i 674

 
 i 297

 
 i 

 
 i 76,294

 
 i 79,806

 
 i 158

 
 i 1,133

 
 i 

 
 i 78,831

State and political subdivision
 i 65,825

 
 i 8,829

 
 i 

 
 i 

 
 i 74,654

 
 i 66,131

 
 i 4,777

 
 i 1,083

 
 i 

 
 i 69,825

Foreign government
 i 20,100

 
 i 1,326

 
 i 86

 
 i 

 
 i 21,340

 
 i 27,466

 
 i 140

 
 i 995

 
 i 

 
 i 26,611

Total fixed maturity securities
$
 i 2,694,974


$
 i 131,824


$
 i 9,007


$
 i 


$
 i 2,817,791


$
 i 2,469,801


$
 i 28,035


$
 i 64,203


$
 i 


$
 i 2,433,633


__________________
 / 
(1)
Redeemable preferred stock is reported within foreign corporate fixed maturity securities. Included within fixed maturity securities are structured securities including residential mortgage-backed securities (“RMBS”), commercial mortgage-backed securities (“CMBS”) and asset-backed securities (“ABS”) (collectively, “Structured Securities”).
The Company held  i no non-income producing fixed maturity securities at either June 30, 2019 and December 31, 2018.
Maturities of Fixed Maturity Securities
 i 
The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at June 30, 2019:
 
Due in One
Year or Less
 
Due After One
Year Through
Five Years
 
Due After Five Years Through
Ten Years
 
Due After Ten
Years
 
Structured
Securities
 
Total Fixed
Maturity
Securities
 
(In thousands)
Amortized cost
$
 i 51,742

 
$
 i 345,953

 
$
 i 898,441

 
$
 i 736,514

 
$
 i 662,324

 
$
 i 2,694,974

Estimated fair value
$
 i 52,130

 
$
 i 353,075

 
$
 i 935,970

 
$
 i 788,311

 
$
 i 688,305

 
$
 i 2,817,791


 / 
 i 
Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. Structured Securities are shown separately, as they are not due at a single maturity.

12

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
4. Investments (continued)

Continuous Gross Unrealized Losses for Fixed Maturity Securities AFS by Sector
 i 
The following table presents the estimated fair value and gross unrealized losses of fixed maturity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position at:
 
 
 
Less than 12 Months
 
Equal to or Greater
than 12 Months
 
Less than 12 Months
 
Equal to or Greater
than 12 Months
 
Estimated
Fair
Value
 
Gross
Unrealized
Losses
 
Estimated
Fair
Value
 
Gross
Unrealized
Losses
 
Estimated
Fair
Value
 
Gross
Unrealized
Losses
 
Estimated
Fair
Value
 
Gross
Unrealized
Losses
 
(Dollars in thousands)
Fixed maturity securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. corporate
$
 i 50,818

 
$
 i 1,217

 
$
 i 66,497

 
$
 i 1,590

 
$
 i 483,424

 
$
 i 15,849

 
$
 i 131,812

 
$
 i 7,185

U.S. government and agency
 i 

 
 i 

 
 i 8,682

 
 i 23

 
 i 102,447

 
 i 1,925

 
 i 296,265

 
 i 11,772

Foreign corporate
 i 46,883

 
 i 1,250

 
 i 39,765

 
 i 3,243

 
 i 194,924

 
 i 10,156

 
 i 72,803

 
 i 7,102

CMBS
 i 183

 
 i 2

 
 i 7,332

 
 i 137

 
 i 119,412

 
 i 1,909

 
 i 44,775

 
 i 2,212

RMBS
 i 8,628

 
 i 143

 
 i 17,840

 
 i 1,019

 
 i 57,510

 
 i 1,746

 
 i 28,573

 
 i 1,136

ABS
 i 24,476

 
 i 183

 
 i 10,594

 
 i 114

 
 i 51,028

 
 i 985

 
 i 11,699

 
 i 148

State and political subdivision
 i 

 
 i 

 
 i 

 
 i 

 
 i 18,260

 
 i 744

 
 i 13,999

 
 i 339

Foreign government
 i 1,571

 
 i 86

 
 i 

 
 i 

 
 i 7,435

 
 i 716

 
 i 6,782

 
 i 279

Total fixed maturity securities
$
 i 132,559


$
 i 2,881


$
 i 150,710


$
 i 6,126


$
 i 1,034,440


$
 i 34,030


$
 i 606,708


$
 i 30,173

Total number of securities in an unrealized loss position
 i 63

 
 
 
 i 60

 
 
 
 i 364

 
 
 
 i 146

 
 

 / 
Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities
Evaluation and Measurement Methodologies
Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the estimated fair value has been below amortized cost; (ii) the potential for impairments when the issuer is experiencing significant financial difficulties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments where the issuer, series of issuers or industry has suffered a catastrophic loss or has exhausted natural resources; (vi) whether the Company has the intent to sell or will more likely than not be required to sell a particular security before the decline in estimated fair value below amortized cost recovers; (vii) with respect to Structured Securities, changes in forecasted cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security; (viii) the potential for impairments due to weakening of foreign currencies on non-functional currency denominated fixed maturity securities that are near maturity; and (ix) other subjective factors, including concentrations and information obtained from regulators and rating agencies.
For securities in an unrealized loss position, an OTTI is recognized in earnings when it is anticipated that the amortized cost will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the OTTI recognized in earnings is the entire difference between the security’s amortized cost and estimated fair value. If neither of these conditions exists, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an OTTI in earnings (“credit loss”). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of OTTI related to other-than-credit factors (“noncredit loss”) is recorded in other comprehensive income (“OCI”).

13

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
4. Investments (continued)

Current Period Evaluation
Based on the Company’s current evaluation of its AFS securities in an unrealized loss position in accordance with its impairment policy, and the Company’s current intentions and assessments (as applicable to the type of security) about holding, selling and any requirements to sell these securities, the Company concluded that these securities were not other-than-temporarily impaired at June 30, 2019.
Gross unrealized losses on fixed maturity securities decreased $ i 55.2 million during the six months ended June 30, 2019 to $ i 9.0 million. The decrease in gross unrealized losses for the six months ended June 30, 2019 was primarily attributable to decreasing longer-term interest rates and narrowing credit spreads.
At June 30, 2019, $ i 928 thousand of the total $ i 9.0 million of gross unrealized losses were from  i one fixed maturity security with an unrealized loss position of  i 20% or more of amortized cost for six months or greater.
Mortgage Loans
Mortgage Loans by Portfolio Segment
 i 
Mortgage loans are summarized as follows at:
 
 
 
Carrying
Value
 
% of
Total
 
Carrying
Value
 
% of
Total
 
(Dollars in thousands)
Mortgage loans:
 
 
 
 
 
 
 
Commercial
$
 i 364,139

 
 i 69.9
 %
 
$
 i 310,681

 
 i 69.3
 %
Agricultural
 i 158,647

 
 i 30.5

 
 i 139,361

 
 i 31.1

Subtotal
 i 522,786

 
 i 100.4

 
 i 450,042

 
 i 100.4

Valuation allowances (1)
( i 2,142
)
 
( i 0.4
)
 
( i 1,937
)
 
( i 0.4
)
Total mortgage loans, net
$
 i 520,644

 
 i 100.0
 %
 
$
 i 448,105

 
 i 100.0
 %

__________________
 / 
(1)
The valuation allowances were primarily from collective evaluation (non-specific loan related).
Information on commercial and agricultural mortgage loans is presented in the tables below.
Valuation Allowance Methodology
Mortgage loans are considered to be impaired when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the loan agreement. Specific valuation allowances are established using the same methodology for both portfolio segments as the excess carrying value of a loan over either (i) the present value of expected future cash flows discounted at the loan’s original effective interest rate, (ii) the estimated fair value of the loan’s underlying collateral if the loan is in the process of foreclosure or otherwise collateral dependent, or (iii) the loan’s observable market price. A common evaluation framework is used for establishing non-specific valuation allowances for both loan portfolio segments; however, a separate non-specific valuation allowance is calculated and maintained for each loan portfolio segment that is based on inputs unique to each loan portfolio segment. Non-specific valuation allowances are established for pools of loans with similar risk characteristics where a property-specific or market-specific risk has not been identified, but for which the Company expects to incur a credit loss. These evaluations are based upon several loan portfolio segment-specific factors, including the Company’s experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. These evaluations are revised as conditions change and new information becomes available.

14

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
4. Investments (continued)

Credit Quality of Commercial Mortgage Loans
The credit quality of commercial mortgage loans was as follows at:
 
Recorded Investment
 
Debt Service Coverage Ratios
 
 
 
% of
Total
 
> 1.20x
 
1.00x - 1.20x
 
< 1.00x
 
Total
 
 
(Dollars in thousands)
 
 
 
 
 
 
 
 
 
Loan-to-value ratios:
 
 
 
 
 
 
 
 
 
Less than 65%
$
 i 335,635

 
$
 i 5,000

 
$
 i 

 
$
 i 340,635

 
 i 93.5
%
65% to 75%
 i 19,224

 
 i 

 
 i 

 
 i 19,224

 
 i 5.3

76% to 80%
 i 4,280

 
 i 

 
 i 

 
 i 4,280

 
 i 1.2

Total
$
 i 359,139


$
 i 5,000


$
 i 


$
 i 364,139

 
 i 100.0
%
 
 
 
 
 
 
 
 
 
Loan-to-value ratios:
 
 
 
 
 
 
 
 
 
Less than 65%
$
 i 273,681

 
$
 i 5,000

 
$
 i 13,447

 
$
 i 292,128

 
 i 94.0
%
65% to 75%
 i 14,257

 
 i 

 
 i 

 
 i 14,257

 
 i 4.6

76% to 80%
 i 4,296

 
 i 

 
 i 

 
 i 4,296

 
 i 1.4

Total
$
 i 292,234


$
 i 5,000


$
 i 13,447


$
 i 310,681

 
 i 100.0
%

Credit Quality of Agricultural Mortgage Loans
 i 
The credit quality of agricultural mortgage loans was as follows at: 
 
 
 
Recorded
Investment
 
% of
Total
 
Recorded
Investment 
 
% of
Total
 
(Dollars in thousands)
Loan-to-value ratios:
 
 
 
 
 
 
 
Less than 65%
$
 i 150,530

 
 i 94.9
%
 
$
 i 133,884

 
 i 96.1
%
65% to 75%
 i 8,117

 
 i 5.1

 
 i 5,477

 
 i 3.9

Total
$
 i 158,647

 
 i 100.0
%
 
$
 i 139,361

 
 i 100.0
%

 / 
Past Due, Nonaccrual and Modified Mortgage Loans
The Company has a high quality, well performing mortgage loan portfolio, with all mortgage loans classified as performing at both June 30, 2019 and December 31, 2018. The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial mortgage loans — 60 days and agricultural mortgage loans — 90 days. The Company had  i no commercial or agricultural mortgage loans past due or in nonaccrual status at either June 30, 2019 or December 31, 2018. During the three months and six months ended June 30, 2019 and 2018, the Company had  i no mortgage loans modified in a troubled debt restructuring.
Cash Equivalents
The carrying value of cash equivalents, which includes securities and other investments with an original or remaining maturity of three months or less at the time of purchase, was $ i 0 and $ i 89.9 million at June 30, 2019 and December 31, 2018, respectively.
Net Unrealized Investment Gains (Losses)
Unrealized investment gains (losses) on fixed maturity securities and the effect on DAC, deferred sales inducements (“DSI”) and future policy benefits, that would result from the realization of the unrealized gains (losses), are included in net unrealized investment gains (losses) in accumulated other comprehensive income (“AOCI”).

15

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
4. Investments (continued)

 i 
The components of net unrealized investment gains (losses), included in AOCI, were as follows:
 
 
 
(In thousands)
Fixed maturity securities
$
 i 122,817

 
$
( i 36,166
)
Derivatives
 i 8,859

 
 i 5,791

Subtotal
 i 131,676

 
( i 30,375
)
Amounts allocated from:
 
 
 
DAC and DSI
( i 15,600
)
 
 i 11,299

Deferred income tax benefit (expense)
( i 24,376
)
 
 i 4,005

Net unrealized investment gains (losses)
$
 i 91,700

 
$
( i 15,071
)

 / 
The changes in net unrealized investment gains (losses) were as follows:
 
Six Months Ended 
 June 30, 2019
 
(In thousands)
$
( i 15,071
)
Unrealized investment gains (losses) during the period
 i 162,051

Unrealized investment gains (losses) relating to:
 
DAC and DSI
( i 26,899
)
Deferred income tax benefit (expense)
( i 28,381
)
Balance, June 30, 2019
$
 i 91,700

Change in net unrealized investment gains (losses)
$
 i 106,771


Concentrations of Credit Risk
There were no investments in any counterparty that were greater than 10% of the Company’s equity, other than the U.S. government and its agencies, at both June 30, 2019 and December 31, 2018.
Invested Assets on Deposit and Pledged as Collateral
 i 
Invested assets on deposit and pledged as collateral are presented below at estimated fair value:
 
 
 
(In thousands)
Invested assets on deposit (regulatory deposits)
$
 i 1,598

 
$
 i 1,482

Invested assets pledged as collateral (1)
 i 6,270

 
 i 158

Total invested assets on deposit and pledged as collateral (2)
$
 i 7,868


$
 i 1,640


__________________
(1)
The Company has pledged invested assets in connection with derivative transactions (see Note 5).
 / 
(2)
The Company held  i no restricted cash at either June 30, 2019 or December 31, 2018.
Variable Interest Entities
The Company has invested in legal entities that are variable interest entities (“VIEs”). VIEs are consolidated when the investor is the primary beneficiary. A primary beneficiary is the variable interest holder in a VIE with both the power to direct the activities of the VIE that most significantly impact the economic performance of the VIE and the obligation to absorb losses, or the right to receive benefits that could potentially be significant to the VIE.
There were  i no material VIEs for which the Company has concluded that it is the primary beneficiary at June 30, 2019 or December 31, 2018.

16

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
4. Investments (continued)

The Company’s investments in unconsolidated VIEs are described below.
Fixed Maturity Securities
The Company invests in U.S. corporate bonds, foreign corporate bonds, and Structured Securities issued by VIEs. The Company is not obligated to provide any financial or other support to these VIEs, other than the original investment. The Company’s involvement with these entities is limited to that of a passive investor. The Company has no unilateral right to appoint or remove the servicer, special servicer, or investment manager, which are generally viewed as having the power to direct the activities that most significantly impact the economic performance of the VIE, nor does the Company function in any of these roles. The Company does not have the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the entity; as a result, the Company has determined it is not the primary beneficiary, or consolidator, of the VIE. The Company’s maximum exposure to loss on these fixed maturity securities is limited to the amortized cost of these investments. See “— Fixed Maturity Securities AFS” for information on these securities.
 i 
The carrying amount and maximum exposure to loss related to the VIEs in which the Company concluded that it holds a variable interest, but is not the primary beneficiary, were as follows at:
 
 
 
Carrying
Amount
 
Maximum
Exposure
to Loss
 
Carrying
Amount
 
Maximum
Exposure
to Loss
 
(In thousands)
Fixed maturity securities
$
 i 396,963

 
$
 i 379,151

 
$
 i 409,699

 
$
 i 409,699


 / 
Net Investment Income
 i 
The components of net investment income were as follows:

Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,

2019
 
2018
 
2019
 
2018

(In thousands)
Investment income:



 
 
 


Fixed maturity securities
$
 i 24,785

 
$
 i 20,937

 
$
 i 47,698

 
$
 i 41,302

Mortgage loans
 i 4,919

 
 i 4,314

 
 i 8,818

 
 i 8,505

Cash, cash equivalents and short-term investments
 i 765

 
 i 298

 
 i 1,152

 
 i 456

Other
 i 361

 
 i 225

 
 i 711

 
 i 321

Subtotal
 i 30,830

 
 i 25,775

 
 i 58,379

 
 i 50,585

Less: Investment expenses
 i 1,114

 
 i 1,686

 
 i 2,170

 
 i 2,565

Net investment income
$
 i 29,716

 
$
 i 24,089

 
$
 i 56,209

 
$
 i 48,020


 / 
See “— Related Party Investment Transactions” for discussion of related party investment expenses.

17

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
4. Investments (continued)

Net Investment Gains (Losses)
Components of Net Investment Gains (Losses)
 i 
The components of net investment gains (losses) were as follows:

Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2019
 
2018
 
2019
 
2018

(In thousands)
Fixed maturity securities
$
 i 5,662

 
$
( i 2,123
)
 
$
 i 5,194

 
$
( i 4,962
)
Mortgage loans
( i 136
)
 
 i 135

 
( i 205
)
 
 i 53

Other
( i 54
)
 
( i 75
)
 
 i 31

 
 i 491

Total net investment gains (losses)
$
 i 5,472

 
$
( i 2,063
)
 
$
 i 5,020

 
$
( i 4,418
)

 / 
Gains (losses) from foreign currency transactions included within net investment gains (losses) were ($ i 7) thousand and $ i 3 thousand for the three months and six months ended June 30, 2019, respectively, and ($ i 122) thousand and $ i 292 thousand for the three months and six months ended June 30, 2018, respectively.
Sales or Disposals of Fixed Maturity Securities
Investment gains and losses on sales of securities are determined on a specific identification basis.  i Proceeds from sales or disposals of fixed maturity securities and the components of fixed maturity securities net investment gains (losses) were as shown in the table below.

Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,

2019
 
2018
 
2019
 
2018

(In thousands)
Proceeds
$
 i 358,205

 
$
 i 73,115

 
$
 i 413,682

 
$
 i 126,676

Gross investment gains
$
 i 6,501

 
$
 i 21

 
$
 i 6,651

 
$
 i 36

Gross investment losses
( i 839
)
 
( i 2,144
)
 
( i 1,457
)
 
( i 4,998
)
Net investment gains (losses)
$
 i 5,662

 
$
( i 2,123
)
 
$
 i 5,194

 
$
( i 4,962
)

Related Party Investment Transactions
The Company receives investment administrative services from MetLife Investment Advisors, LLC, which was considered a related party investment manager until the completion of the MetLife Divestiture. The related investment administrative service charges were $ i 1.5 million and $ i 2.3 million for the three months and six months ended June 30, 2018, respectively. All of the charges reported as related party activity in 2018 occurred prior to the MetLife Divestiture. See Note 1 regarding the MetLife Divestiture.
 i 
5. Derivatives
 i 
Accounting for Derivatives
Freestanding Derivatives
Freestanding derivatives are carried on the Company’s balance sheet either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement.
If a derivative is not designated or did not qualify as an accounting hedge, changes in the estimated fair value of the derivative are reported in net derivative gains (losses).The Company generally reports cash received or paid for a derivative in the investing activity section of the statement of cash flows except for cash flows of certain derivative options with deferred premiums, which are reported in the financing activity section of the statement of cash flows.

18

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
5. Derivatives (continued)

Hedge Accounting
The Company primarily designates derivatives as a hedge of a forecasted transaction or a variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in fair value are recorded in OCI and subsequently reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.
To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship.
The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative or hedged item expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument.
When hedge accounting is discontinued the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses). The changes in estimated fair value of derivatives previously recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item. When the hedged item matures or is sold, or the forecasted transaction is not probable of occurring, the Company immediately reclassifies any remaining balances in OCI to net derivative gains (losses).
Embedded Derivatives
The Company has certain insurance and reinsurance contracts that contain embedded derivatives which are required to be separated from their host contracts and reported as derivatives. These host contracts include: variable annuities with guaranteed minimum benefits; index-linked annuities that are directly written; and ceded reinsurance of variable annuity with guaranteed minimum benefits. Embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables on the balance sheets. Embedded derivatives within liability host contracts are presented within policyholder account balances on the balance sheets. Changes in the estimated fair value of the embedded derivative are reported in net derivative gains (losses).
Derivative Strategies
The Company maintains an overall risk management strategy that incorporates the use of derivative instruments to minimize its exposure to various market risks, including interest rate, foreign currency exchange rate and equity market.
Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates and/or financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. The Company’s OTC derivatives are settled bilateral contracts between two counterparties (“OTC-bilateral”).
Interest Rate Derivatives
Interest rate caps: The Company uses interest rate caps to protect against interest rate exposure arising from mismatches between assets and liabilities. Interest rate caps are used in nonqualifying hedging relationships.
Foreign Currency Exchange Rate Derivatives
Foreign currency swaps: The Company uses foreign currency swaps to convert foreign currency denominated cash flows to U.S. dollars to reduce cash flow fluctuations due to changes in currency exchange rates. Foreign currency swaps are used in cash flow and nonqualifying hedging relationships.
Equity Derivatives
Equity index options: The Company uses equity index options to hedge index-linked annuity products against adverse changes in equity markets. Equity index options are used in nonqualifying hedging relationships.

19

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
5. Derivatives (continued)

Primary Risks Managed by Derivatives
 i 
The following table presents the primary underlying risk exposure, gross notional amount, and estimated fair value of the Company’s derivatives, held at:
 
 
 
 
 
Primary Underlying Risk Exposure
 
Gross
Notional
Amount
 
Estimated Fair Value
 
Gross
Notional
Amount
 
Estimated Fair Value
 
Assets
 
Liabilities
 
Assets
 
Liabilities
 
 
 
(In thousands)
Derivatives Designated as Hedging Instruments:
Cash flow hedges:
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency swaps
Foreign currency exchange rate
 
$
 i 89,224

 
$
 i 8,754

 
$
 i 249

 
$
 i 82,704

 
$
 i 5,649

 
$
 i 187

Derivatives Not Designated or Not Qualifying as Hedging Instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate caps
Interest rate
 
 i 800,000

 
 i 2,925

 
 i 

 
 i 800,000

 
 i 9,284

 
 i 

Foreign currency swaps
Foreign currency exchange rate
 
 i 17,892

 
 i 4,249

 
 i 123

 
 i 28,133

 
 i 3,395

 
 i 144

Equity index options
Equity market
 
 i 1,692,574

 
 i 33,462

 
 i 14,859

 
 i 2,154,321

 
 i 10,389

 
 i 96

Total non-designated or nonqualifying derivatives
 
 
 i 2,510,466

 
 i 40,636

 
 i 14,982

 
 i 2,982,454

 
 i 23,068

 
 i 240

Embedded derivatives:
Ceded guaranteed minimum income benefits
Other
 
N/A

 
 i 330,407

 
 i 

 
N/A

 
 i 298,112

 
 i 

Direct guaranteed minimum benefits
Other
 
N/A

 
 i 

 
( i 23,278
)
 
N/A

 
 i 

 
( i 18,811
)
Direct index-linked annuities
Other
 
N/A

 
 i 

 
 i 93,212

 
N/A

 
 i 

 
 i 5,617

Total embedded derivatives
Other
 
N/A

 
 i 330,407

 
 i 69,934

 
N/A

 
 i 298,112

 
( i 13,194
)
Total
 
 
$
 i 2,599,690

 
$
 i 379,797

 
$
 i 85,165

 
$
 i 3,065,158

 
$
 i 326,829

 
$
( i 12,767
)

 / 

20

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
5. Derivatives (continued)

 i  i 
The following tables present the amount and location of gains (losses), including earned income, recognized for derivatives and gains (losses) pertaining to hedged items presented in net derivative gains (losses):
 
Net Derivative
Gains (Losses)
Recognized for
Derivatives
 
Net Derivative
Gains (Losses)
Recognized for
Hedged Items 
 
Net Investment Income
 
Amount of
Gains (Losses) deferred in AOCI
 
(In thousands)
Three Months Ended June 30, 2019
 
 
 
 
 
 
 
Derivatives Designated as Hedging Instruments:
 
 
 
 
 
 
 
Cash flow hedges:
 
 
 
 
 
 
 
Foreign currency exchange rate derivatives
$
 i 3

 
$
( i 8
)
 
$
 i 353

 
$
 i 4,106

Total cash flow hedges
 i 3

 
( i 8
)
 
 i 353

 
 i 4,106

Derivatives Not Designated or Not Qualifying as Hedging Instruments:
 
 
 
 
 
 
 
Interest rate derivatives
( i 1,847
)
 
 i 

 
 i 

 
 i 

Foreign currency exchange rate derivatives
 i 1,091

 
( i 96
)
 
 i 

 
 i 

Equity derivatives
 i 13,571

 
 i 

 
 i 

 
 i 

Embedded derivatives
 i 14,594

 
 i 

 
 i 

 
 i 

Total non-qualifying hedges
 i 27,409

 
( i 96
)
 
 i 

 
 i 

Total
$
 i 27,412

 
$
( i 104
)
 
$
 i 353

 
$
 i 4,106

 
 
 
 
 
 
 
 
Three Months Ended June 30, 2018
 
 
 
 
 
 
 
Derivatives Designated as Hedging Instruments:
 
 
 
 
 
 
 
Cash flow hedges:
 
 
 
 
 
 
 
Foreign currency exchange rate derivatives
$
 i 49

 
$
 i 

 
$
 i 215

 
$
 i 3,576

Total cash flow hedges
 i 49

 
 i 

 
 i 215

 
 i 3,576

Derivatives Not Designated or Not Qualifying as Hedging Instruments:
 
 
 
 
 
 
 
Interest rate derivatives
 i 12

 
 i 

 
 i 

 
 i 

Foreign currency exchange rate derivatives
 i 1,265

 
( i 256
)
 
 i 

 
 i 

Equity derivatives
 i 1,722

 
 i 

 
 i 

 
 i 

Embedded derivatives
( i 23,904
)
 
 i 

 
 i 

 
 i 

Total non-qualifying hedges
( i 20,905
)
 
( i 256
)
 
 i 

 
 i 

Total
$
( i 20,856
)
 
$
( i 256
)
 
$
 i 215

 
$
 i 3,576



 / 
 / 

21

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
5. Derivatives (continued)

 
Net Derivative
Gains (Losses)
Recognized for
Derivatives
 
Net Derivative
Gains (Losses)
Recognized for
Hedged Items
 
Net Investment Income
 
Amount of
Gains (Losses) deferred in AOCI
 
(In thousands)
Six Months Ended June 30, 2019
 
 
 
 
 
 
 
Derivatives Designated as Hedging Instruments:
 
 
 
 
 
 
 
Cash flow hedges:
 
 
 
 
 
 
 
Foreign currency exchange rate derivatives
$
 i 3

 
$
( i 14
)
 
$
 i 623

 
$
 i 3,071

Total cash flow hedges
 i 3

 
( i 14
)
 
 i 623

 
 i 3,071

Derivatives Not Designated or Not Qualifying as Hedging Instruments:
 
 
 
 
 
 
 
Interest rate derivatives
( i 6,359
)
 
 i 

 
 i 

 
 i 

Foreign currency exchange rate derivatives
 i 1,055

 
( i 2
)
 
 i 

 
 i 

Equity derivatives
 i 49,687

 
 i 

 
 i 

 
 i 

Embedded derivatives
( i 20,307
)
 
 i 

 
 i 

 
 i 

Total non-qualifying hedges
 i 24,076

 
( i 2
)
 
 i 

 
 i 

Total
$
 i 24,079

 
$
( i 16
)
 
$
 i 623

 
$
 i 3,071

 
 
 
 
 
 
 
 
Six Months Ended June 30, 2018
 
 
 
 
 
 
 
Derivatives Designated as Hedging Instruments:
 
 
 
 
 
 
 
Cash flow hedges:
 
 
 
 
 
 
 
Foreign currency exchange rate derivatives
$
 i 55

 
$
 i 

 
$
 i 401

 
$
 i 902

Total cash flow hedges
 i 55

 
 i 

 
 i 401

 
 i 902

Derivatives Not Designated or Not Qualifying as Hedging Instruments:
 
 
 
 
 
 
 
Interest rate derivatives
( i 3,990
)
 
 i 

 
 i 

 
 i 

Foreign currency exchange rate derivatives
 i 293

 
( i 104
)
 
 i 

 
 i 

Equity derivatives
( i 7,014
)
 
 i 

 
 i 

 
 i 

Embedded derivatives
( i 54,614
)
 
 i 

 
 i 

 
 i 

Total non-qualifying hedges
( i 65,325
)
 
( i 104
)
 
 i 

 
 i 

Total
$
( i 65,270
)
 
$
( i 104
)
 
$
 i 401

 
$
 i 902

At June 30, 2019 and December 31, 2018, the balance in AOCI associated with cash flow hedges was $ i 8.9 million and $ i 5.8 million, respectively.
Counterparty Credit Risk
The Company may be exposed to credit-related losses in the event of counterparty nonperformance on derivative instruments. Generally, the credit exposure is the fair value at the reporting date less any collateral received from the counterparty.
The Company manages its credit risk by: (i) entering into derivative transactions with creditworthy counterparties governed by master netting agreements; (ii) trading through regulated exchanges and central clearing counterparties; (iii) obtaining collateral, such as cash and securities, when appropriate; and (iv) setting limits on single party credit exposures which are subject to periodic management review.
See Note 6 for a description of the impact of credit risk on the valuation of derivatives.

22

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
5. Derivatives (continued)

 i  i 
The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at: 
 
 
 
 
Gross Amounts Not Offset on the Balance Sheets
 
 
 
 
 
 
 
 
Gross Amount Recognized
 
Financial Instruments (1)
 
Collateral Received/Pledged (2)
 
Net Amount
 
Off-balance Sheet Securities Collateral (3)
 
Net Amount After Securities Collateral
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
 
 
Derivative assets
 
$
 i 49,664

 
$
( i 10,170
)
 
$
( i 31,818
)
 
$
 i 7,676

 
$
( i 3,915
)
 
$
 i 3,761

Derivative liabilities
 
$
 i 15,211

 
$
( i 10,170
)
 
$
 i 

 
$
 i 5,041

 
$
( i 5,041
)
 
$
 i 

 
 
 
 
 
 
 
 
 
 
 
 
Derivative assets
 
$
 i 29,006

 
$
( i 365
)
 
$
( i 23,197
)
 
$
 i 5,444

 
$
( i 2,212
)
 
$
 i 3,232

Derivative liabilities
 
$
 i 411

 
$
( i 365
)
 
$
 i 

 
$
 i 46

 
$
( i 46
)
 
$
 i 

__________________
(1)
Represents amounts subject to an enforceable master netting agreement or similar agreement.
(2)
The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreement.
(3)
Securities collateral received by the Company is not recorded on the balance sheet. Amounts do not include excess of collateral pledged or received.
 / 
 / 
The Company’s collateral arrangements generally require the counterparty in a net liability position, after considering the effect of netting agreements, to pledge collateral when the amount owed by that counterparty reaches a minimum transfer amount. Certain of these arrangements also include credit contingent provisions which permit the party with positive fair value to terminate the derivative at the current fair value or demand immediate full collateralization from the party in a net liability position, in the event that the financial strength or credit rating of the party in a net liability position falls below a certain level.
 i 
The following table presents the aggregate estimated fair value of derivatives in a net liability position containing such credit contingent provisions and the aggregate estimated fair value of assets posted as collateral for such instruments.

 
 
 
 
 
(In thousands)
Estimated fair value of derivatives in a net liability position (1)
 
$
 i 5,041

 
$
 i 46

Estimated Fair Value of Collateral Provided (2):
 
 
 
 
Fixed maturity securities
 
$
 i 6,270

 
$
 i 158

__________________
(1)
After taking into consideration the existence of netting agreements.
 / 
(2)
Substantially all of the Company’s collateral arrangements provide for daily posting of collateral for the full value of the derivative contract. As a result, if the credit contingent provisions of derivative contracts in a net liability position were triggered minimal additional assets would be required to be posted as collateral or needed to settle the instruments immediately.

23

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

 i 
6. Fair Value
Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts.
Recurring Fair Value Measurements
The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, are presented below. Investments that do not have a readily determinable fair value and are measured at net asset value (or equivalent) as a practical expedient to estimated fair value are excluded from the fair value hierarchy.
 i 
 
 
Fair Value Hierarchy
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Estimated
Fair Value
 
(In thousands)
Assets
 
 
 
 
 
 
 
Fixed maturity securities:
 
 
 
 
 
 
 
U.S. corporate
$
 i 

 
$
 i 1,302,367

 
$
 i 3,713

 
$
 i 1,306,080

U.S. government and agency
 i 191,142

 
 i 130,254

 
 i 

 
 i 321,396

Foreign corporate
 i 

 
 i 388,308

 
 i 17,708

 
 i 406,016

CMBS
 i 

 
 i 295,060

 
 i 

 
 i 295,060

RMBS
 i 

 
 i 316,951

 
 i 

 
 i 316,951

ABS
 i 

 
 i 76,294

 
 i 

 
 i 76,294

State and political subdivision
 i 

 
 i 74,654

 
 i 

 
 i 74,654

Foreign government
 i 

 
 i 21,340

 
 i 

 
 i 21,340

Total fixed maturity securities
 i 191,142

 
 i 2,605,228

 
 i 21,421

 
 i 2,817,791

Derivative assets: (1)
 
 
 
 
 
 
 
Interest rate
 i 

 
 i 2,925

 
 i 

 
 i 2,925

Foreign currency exchange rate
 i 

 
 i 13,003

 
 i 

 
 i 13,003

Equity market
 i 

 
 i 33,462

 
 i 

 
 i 33,462

Total derivative assets
 i 

 
 i 49,390

 
 i 

 
 i 49,390

Embedded derivatives within asset host contracts (2)
 i 

 
 i 

 
 i 330,407

 
 i 330,407

Separate account assets
 i 

 
 i 4,612,744

 
 i 

 
 i 4,612,744

Total assets
$
 i 191,142

 
$
 i 7,267,362

 
$
 i 351,828

 
$
 i 7,810,332

Liabilities
 
 
 
 
 
 
 
Derivative liabilities: (1)
 
 
 
 
 
 
 
Foreign currency exchange rate
$
 i 

 
$
 i 372

 
$
 i 

 
$
 i 372

Equity market
 i 

 
 i 14,859

 
 i 

 
 i 14,859

Total derivative liabilities
 i 

 
 i 15,231

 
 i 

 
 i 15,231

Embedded derivatives within liability host contracts (2)
 i 

 
 i 

 
 i 69,934

 
 i 69,934

Total liabilities
$
 i 

 
$
 i 15,231

 
$
 i 69,934

 
$
 i 85,165

 / 

24

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
6. Fair Value (continued)

 
 
Fair Value Hierarchy
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Estimated
Fair Value
 
(In thousands)
Assets
 
 
 
 
 
 
 
Fixed maturity securities:
 
 
 
 
 
 
 
U.S. corporate
$
 i 

 
$
 i 869,498

 
$
 i 3,546

 
$
 i 873,044

U.S. government and agency
 i 389,491

 
 i 118,028

 
 i 

 
 i 507,519

Foreign corporate
 i 

 
 i 342,600

 
 i 9,764

 
 i 352,364

CMBS
 i 

 
 i 318,120

 
 i 4,731

 
 i 322,851

RMBS
 i 

 
 i 202,588

 
 i 

 
 i 202,588

ABS
 i 

 
 i 78,831

 
 i 

 
 i 78,831

State and political subdivision
 i 

 
 i 69,825

 
 i 

 
 i 69,825

Foreign government
 i 

 
 i 26,611

 
 i 

 
 i 26,611

Total fixed maturity securities
 i 389,491

 
 i 2,026,101

 
 i 18,041

 
 i 2,433,633

Derivative assets: (1)
 
 
 
 
 
 
 
Interest rate
 i 

 
 i 9,284

 
 i 

 
 i 9,284

Foreign currency exchange rate
 i 

 
 i 8,572

 
 i 472

 
 i 9,044

Equity market
 i 

 
 i 10,389

 
 i 

 
 i 10,389

Total derivative assets
 i 

 
 i 28,245

 
 i 472

 
 i 28,717

Embedded derivatives within asset host contracts (2)
 i 

 
 i 

 
 i 298,112

 
 i 298,112

Separate account assets
 i 

 
 i 4,268,423

 
 i 

 
 i 4,268,423

Total assets
$
 i 389,491

 
$
 i 6,322,769

 
$
 i 316,625

 
$
 i 7,028,885

Liabilities
 
 
 
 
 
 
 
Derivative liabilities: (1)
 
 
 
 
 
 
 
Foreign currency exchange rate
$
 i 

 
$
 i 331

 
$
 i 

 
$
 i 331

Equity market
 i 

 
 i 96

 
 i 

 
 i 96

Total derivative liabilities
 i 

 
 i 427

 
 i 

 
 i 427

Embedded derivatives within liability host contracts (2)
 i 

 
 i 

 
( i 13,194
)
 
( i 13,194
)
Total liabilities
$
 i 

 
$
 i 427

 
$
( i 13,194
)
 
$
( i 12,767
)
______________
(1)
Derivative assets are presented within other invested assets on the balance sheets and derivative liabilities are presented within other liabilities on the balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the balance sheets.
(2)
Embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables and other invested assets on the balance sheets. Embedded derivatives within liability host contracts are presented within policyholder account balances on the balance sheets.
Valuation Controls and Procedures
The Company monitors and provides oversight of valuation controls and policies for securities, mortgage loans and derivatives, which are primarily executed by its valuation service providers. The valuation methodologies used to determine fair values prioritize the use of observable market prices and market-based parameters and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. The valuation methodologies for securities, mortgage loans and derivatives are reviewed on an ongoing basis and revised when necessary. In addition, the Chief Accounting Officer periodically reports to the Audit Committee of Brighthouse Financial’s Board of Directors regarding compliance with fair value accounting standards.

25

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
6. Fair Value (continued)

The fair value of financial assets and financial liabilities is based on quoted market prices, where available. The Company assesses whether prices received represent a reasonable estimate of fair value through controls designed to ensure valuations represent an exit price. Valuation service providers perform several controls, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the fair value estimates, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. Independent non-binding broker quotes, also referred to herein as “consensus pricing,” are used for non-significant portion of the portfolio. Prices received from independent brokers are assessed to determine if they represent a reasonable estimate of fair value by considering such pricing relative to the current market dynamics and current pricing for similar financial instruments.
Valuation service providers also apply a formal process to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained. If obtaining an independent non-binding broker quotation is unsuccessful, valuation service providers will use the last available price.
The Company reviews outputs of the valuation service providers’ controls and performs additional controls, including certain monthly controls, which include but are not limited to, performing balance sheet analytics to assess reasonableness of period to period pricing changes, including any price adjustments. Price adjustments are applied if prices or quotes received from independent pricing services or brokers are not considered reflective of market activity or representative of estimated fair value. The Company did not have significant price adjustments during the six months ended June 30, 2019.
Determination of Fair Value
Fixed Maturity Securities
The fair values for actively traded marketable bonds, primarily U.S. government and agency securities, are determined using the quoted market prices and are classified as Level 1 assets. For fixed maturity securities classified as Level 2 assets, fair values are determined using either a market or income approach and are valued based on a variety of observable inputs as described below.
U.S. corporate and foreign corporate securities: Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, benchmark yields, spreads off benchmark yields, new issuances, issuer rating, trades of identical or comparable securities, or duration. Privately-placed securities are valued using the additional key inputs: market yield curve, call provisions, observable prices and spreads for similar public or private securities that incorporate the credit quality and industry sector of the issuer, and delta spread adjustments to reflect specific credit-related issues.
U.S. government and agency, state and political subdivision and foreign government securities: Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, benchmark U.S. Treasury yield or other yields, spread off the U.S. Treasury yield curve for the identical security, issuer ratings and issuer spreads, broker dealer quotes, and comparable securities that are actively traded.
Structured Securities: Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, spreads for actively traded securities, spreads off benchmark yields, expected prepayment speeds and volumes, current and forecasted loss severity, ratings, geographic region, weighted average coupon and weighted average maturity, average delinquency rates and debt-service coverage ratios. Other issuance-specific information is also used, including, but not limited to; collateral type, structure of the security, vintage of the loans, payment terms of the underlying asset, payment priority within tranche, and deal performance.

26

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
6. Fair Value (continued)

Derivatives
The fair values for OTC-bilateral derivatives classified as Level 2 assets or liabilities are determined using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models which are based on market standard valuation methodologies and a variety of observable inputs.
The significant inputs to the pricing models for most OTC-bilateral derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Certain OTC-bilateral derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments.
Most inputs for OTC-bilateral derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company’s derivatives and could materially affect net income. 
The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral derivatives using standard swap curves which may include a spread to the risk-free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company’s ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period.
Embedded Derivatives
Embedded derivatives principally include certain direct variable annuity guarantees and certain affiliated ceded reinsurance agreements related to such variable annuity guarantees. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income.
The Company issues certain variable annuity products with guaranteed minimum benefits. GMWBs, GMABs and certain GMIBs contain embedded derivatives, which are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances on the balance sheets.
The Company determines the fair value of these embedded derivatives by estimating the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations of policyholder behavior. The calculation is based on in-force business, and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk-free rates. The percentage of fees included in the initial fair value measurement is not updated in subsequent periods.
Capital market assumptions, such as risk-free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience.

27

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
6. Fair Value (continued)

The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for BHF’s debt. These observable spreads are then adjusted to reflect the priority of these liabilities and claims paying ability of the issuing insurance subsidiaries as compared to BHF’s overall financial strength.
Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees.
Transfers Into or Out of Level 3:
Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable.
Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)
 i 
The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:
 
 
 
 
 
 
 
 
 
Impact of
Increase in Input
on Estimated
Fair Value
 
Valuation Techniques
 
Significant
Unobservable Inputs
 

Range
 
Range
 
Embedded derivatives
 
 
 
 
 
 
 
 
 
 
Direct, assumed and ceded guaranteed minimum benefits
Option pricing techniques
 
Mortality rates
 
 i 0.02%
-
 i 11.31%
 
 i 0.02%
-
 i 11.31%
 
Decrease (1)
 
 
 
 
Lapse rates
 
 i 0.25%
-
 i 16.00%
 
 i 0.25%
-
 i 16.00%
 
Decrease (2)
 
 
 
 
Utilization rates
 
 i 0.00%
-
 i 25.00%
 
 i 0.00%
-
 i 25.00%
 
Increase (3)
 
 
 
 
Withdrawal rates
 
 i 0.25%
-
 i 10.00%
 
 i 0.25%
-
 i 10.00%
 
(4)
 
 
 
 
Long-term equity volatilities
 
 i 16.50%
-
 i 22.00%
 
 i 16.50%
-
 i 22.00%
 
Increase (5)
 
 
 
 
Nonperformance risk spread
 
 i 0.94%
-
 i 2.43%
 
 i 1.91%
-
 i 2.66%
 
Decrease (6)
______________
(1)
Mortality rates vary by age and by demographic characteristics such as gender. Range shown reflects the mortality rate for policyholders between 35 and 90 years old, which represents the majority of the business with living benefits. Mortality rate assumptions are set based on company experience and include an assumption for mortality improvement.
(2)
Range reflects base lapse rates for major product categories for duration 1-20, which represents majority of business with living benefit riders. Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in-the-money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies.
(3)
The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible in a given year. The range shown represents the floor and cap of the GMIB dynamic election rates across varying levels of in-the-money. For lifetime withdrawal guarantee riders, the assumption is that everyone will begin withdrawals once account value reaches zero which is equivalent to a 100% utilization rate. Utilization rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder.
 / 

28

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
6. Fair Value (continued)

(4)
The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.
(5)
Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(6)
Nonperformance risk spread varies by duration. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.
The Company does not develop unobservable inputs used in measuring fair value for all other assets and liabilities classified within Level 3; therefore, these are not included in the table above. The other Level 3 assets and liabilities primarily included fixed maturity securities and derivatives. For fixed maturity securities valued based on non-binding broker quotes, an increase (decrease) in credit spreads would result in a higher (lower) fair value. For derivatives valued based on third-party pricing models, an increase (decrease) in credit spreads would generally result in a higher (lower) fair value.

29

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
6. Fair Value (continued)

 i 
The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):
 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Fixed Maturity Securities
 
 
 
 
 
 
Corporate (1)
 
Structured Securities
 
Net Derivatives (2)
 
Net Embedded
Derivatives (3)
 
 
(In thousands)
Three Months Ended June 30, 2019
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
 i 13,725

 
$
 i 10,177

 
$
 i 

 
$
 i 261,740

Total realized/unrealized gains (losses) included in net income (loss) (4) (5)
 
 i 9

 
 i 

 
 i 

 
 i 14,594

Total realized/unrealized gains (losses) included in AOCI
 
( i 187
)
 
 i 

 
 i 

 
 i 

Purchases (6)
 
 i 9,000

 
 i 

 
 i 

 
 i 

Sales (6)
 
( i 63
)
 
 i 

 
 i 

 
 i 

Issuances (6)
 
 i 

 
 i 

 
 i 

 
 i 

Settlements (6)
 
 i 

 
 i 

 
 i 

 
( i 15,861
)
Transfers into Level 3 (7)
 
 i 

 
 i 

 
 i 

 
 i 

Transfers out of Level 3 (7)
 
( i 1,063
)
 
( i 10,177
)
 
 i 

 
 i 

Balance, end of period
 
$
 i 21,421

 
$
 i 

 
$
 i 

 
$
 i 260,473

Three Months Ended June 30, 2018
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
 i 92,080

 
$
 i 21,337

 
$
 i 

 
$
 i 311,011

Total realized/unrealized gains (losses) included in net income (loss) (4) (5)
 
( i 221
)
 
 i 78

 
 i 

 
( i 23,904
)
Total realized/unrealized gains (losses) included in AOCI
 
( i 3,003
)
 
 i 98

 
 i 

 
 i 

Purchases (6)
 
 i 10,498

 
 i 6,901

 
 i 

 
 i 

Sales (6)
 
( i 4,109
)
 
( i 301
)
 
 i 

 
 i 

Issuances (6)
 
 i 

 
 i 

 
 i 

 
 i 

Settlements (6)
 
 i 

 
 i 

 
 i 

 
( i 5,922
)
Transfers into Level 3 (7)
 
 i 

 
 i 

 
 i 

 
 i 

Transfers out of Level 3 (7)
 
 i 

 
( i 1,951
)
 
 i 

 
 i 

Balance, end of period
 
$
 i 95,245

 
$
 i 26,162

 
$
 i 

 
$
 i 281,185

Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at June 30, 2019 (8)
 
$
 i 9

 
$
 i 

 
$
 i 

 
$
 i 25,980

Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at June 30, 2018 (8)
 
$
 i 4

 
$
 i 78

 
$
 i 

 
$
( i 15,574
)








 / 

30

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
6. Fair Value (continued)

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Fixed Maturity Securities
 
 
 
 
 
 
Corporate (1)
 
Structured Securities
 
Net Derivatives (2)
 
Net Embedded
Derivatives (3)
 
 
(In thousands)
Six Months Ended June 30, 2019
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
 i 13,310

 
$
 i 4,731

 
$
 i 472

 
$
 i 311,306

Total realized/unrealized gains (losses) included in net income (loss) (4) (5)
 
 i 18

 
 i 

 
 i 

 
( i 20,307
)
Total realized/unrealized gains (losses) included in AOCI
 
 i 201

 
 i 

 
 i 

 
 i 

Purchases (6)
 
 i 9,000

 
 i 

 
 i 

 
 i 

Sales (6)
 
( i 111
)
 
 i 

 
 i 

 
 i 

Issuances (6)
 
 i 

 
 i 

 
 i 

 
 i 

Settlements (6)
 
 i 

 
 i 

 
 i 

 
( i 30,526
)
Transfers into Level 3 (7)
 
 i 262

 
 i 

 
 i 

 
 i 

Transfers out of Level 3 (7)
 
( i 1,259
)
 
( i 4,731
)
 
( i 472
)
 
 i 

Balance, end of period
 
$
 i 21,421

 
$
 i 

 
$
 i 

 
$
 i 260,473

Six Months Ended June 30, 2018
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
 i 95,950

 
$
 i 19,557

 
$
 i 

 
$
 i 347,633

Total realized/unrealized gains (losses) included in net income (loss) (4) (5)
 
( i 220
)
 
 i 186

 
 i 

 
( i 54,614
)
Total realized/unrealized gains (losses) included in AOCI
 
( i 3,778
)
 
 i 208

 
 i 

 
 i 

Purchases (6)
 
 i 11,285

 
 i 6,901

 
 i 

 
 i 

Sales (6)
 
( i 4,826
)
 
( i 690
)
 
 i 

 
 i 

Issuances (6)
 
 i 

 
 i 

 
 i 

 
 i 

Settlements (6)
 
 i 

 
 i 

 
 i 

 
( i 11,834
)
Transfers into Level 3 (7)
 
 i 

 
 i 

 
 i 

 
 i 

Transfers out of Level 3 (7)
 
( i 3,166
)
 
 i 

 
 i 

 
 i 

Balance, end of period
 
$
 i 95,245

 
$
 i 26,162

 
$
 i 

 
$
 i 281,185

Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at June 30, 2019 (8)
 
$
 i 18

 
$
 i 

 
$
 i 

 
$
 i 39,060

Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at June 30, 2018 (8)
 
$
 i 8

 
$
 i 187

 
$
 i 

 
$
( i 48,637
)
______________
(1)
Comprised of U.S. and foreign corporate securities.
(2)
Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.
(3)
Embedded derivative assets and liabilities are presented net for purposes of the rollforward.
(4)
Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with net embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net embedded derivatives are reported in net derivative gains (losses).
(5)
Interest accruals, as well as cash interest coupons received, are excluded from the rollforward.
(6)
Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.

31

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
6. Fair Value (continued)

(7)
Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.
(8)
Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods. Substantially all changes in unrealized gains (losses) included in net income (loss) for net embedded derivatives are reported in net derivative gains (losses).
Fair Value of Financial Instruments Carried at Other Than Fair Value
The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income and payables for collateral under derivative transactions. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the tables below are not considered financial instruments subject to this disclosure.
 i 
The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:
 
 
 
 
Fair Value Hierarchy
 
 
 
Carrying
Value
Level 1
 
Level 2
 
Level 3
Total
Estimated
Fair Value
 
(In thousands)
Assets
 
 
 
 
 
 
 
 
 
Mortgage loans
$
 i 520,644

 
$
 i 

 
$
 i 

 
$
 i 538,265

 
$
 i 538,265

Premiums, reinsurance and other receivables
$
 i 18,403

 
$
 i 

 
$
 i 3,213

 
$
 i 14,265

 
$
 i 17,478

Liabilities
 
 
 
 
 
 
 
 
 
Policyholder account balances
$
 i 995,188

 
$
 i 

 
$
 i 

 
$
 i 956,791

 
$
 i 956,791

Other liabilities
$
 i 35,047

 
$
 i 

 
$
 i 35,047

 
$
 i 

 
$
 i 35,047

 / 
 
 
 
 
Fair Value Hierarchy
 
 
 
Carrying
Value
Level 1
 
Level 2
 
Level 3
Total
Estimated
Fair Value
 
(In thousands)
Assets
 
 
 
 
 
 
 
 
 
Mortgage loans
$
 i 448,105

 
$
 i 

 
$
 i 

 
$
 i 447,510

 
$
 i 447,510

Premiums, reinsurance and other receivables
$
 i 20,001

 
$
 i 

 
$
 i 2,314

 
$
 i 15,512

 
$
 i 17,826

Liabilities
 
 
 
 
 
 
 
 
 
Policyholder account balances
$
 i 1,056,419

 
$
 i 

 
$
 i 

 
$
 i 949,916

 
$
 i 949,916

Other liabilities
$
 i 10,399

 
$
 i 

 
$
 i 10,399

 
$
 i 

 
$
 i 10,399


32

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

 i 
7. Equity
Capital Transactions
During the first quarter of 2019, the Company received a cash capital contribution of $ i 75 million from Brighthouse Life Insurance Company.
Accumulated Other Comprehensive Income (Loss)
 i 
Information regarding changes in the balances of each component of AOCI was as follows:
 
Three Months Ended 
 June 30, 2019
 
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
 
Unrealized
Gains (Losses)
on Derivatives
 
Total
 
(In thousands)
$
 i 26,235

 
$
 i 4,614

 
$
 i 30,849

OCI before reclassifications
 i 78,579

 
 i 4,106

 
 i 82,685

Deferred income tax benefit (expense)
( i 16,501
)
 
( i 862
)
 
( i 17,363
)
AOCI before reclassifications, net of income tax
 i 88,313

 
 i 7,858

 
 i 96,171

Amounts reclassified from AOCI
( i 5,655
)
 
( i 3
)
 
( i 5,658
)
Deferred income tax benefit (expense)
 i 1,186

 
 i 1

 
 i 1,187

Amounts reclassified from AOCI, net of income tax
( i 4,469
)
 
( i 2
)
 
( i 4,471
)
Balance, June 30, 2019
$
 i 83,844

 
$
 i 7,856

 
$
 i 91,700

 
Three Months Ended 
 June 30, 2018
 
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
 
Unrealized
Gains (Losses)
on Derivatives
 
Total
 
(In thousands)
$
 i 1,150

 
$
( i 1,812
)
 
$
( i 662
)
OCI before reclassifications
( i 24,793
)
 
 i 3,576

 
( i 21,217
)
Deferred income tax benefit (expense)
 i 5,206

 
( i 751
)
 
 i 4,455

AOCI before reclassifications, net of income tax
( i 18,437
)
 
 i 1,013

 
( i 17,424
)
Amounts reclassified from AOCI
 i 2,117

 
( i 49
)
 
 i 2,068

Deferred income tax benefit (expense)
( i 445
)
 
 i 11

 
( i 434
)
Amounts reclassified from AOCI, net of income tax
 i 1,672

 
( i 38
)
 
 i 1,634

Balance, June 30, 2018
$
( i 16,765
)
 
$
 i 975

 
$
( i 15,790
)

33

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
7. Equity (continued)

 
Six Months Ended 
 June 30, 2019
 
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
 
Unrealized
Gains (Losses)
on Derivatives
 
Total
 
(In thousands)
$
( i 20,503
)
 
$
 i 5,432

 
$
( i 15,071
)
OCI before reclassifications
 i 137,268

 
 i 3,071

 
 i 140,339

Deferred income tax benefit (expense)
( i 28,826
)
 
( i 645
)
 
( i 29,471
)
AOCI before reclassifications, net of income tax
 i 87,939

 
 i 7,858

 
 i 95,797

Amounts reclassified from AOCI
( i 5,184
)
 
( i 3
)
 
( i 5,187
)
Deferred income tax benefit (expense)
 i 1,089

 
 i 1

 
 i 1,090

Amounts reclassified from AOCI, net of income tax
( i 4,095
)
 
( i 2
)
 
( i 4,097
)
Balance, June 30, 2019
$
 i 83,844

 
$
 i 7,856

 
$
 i 91,700

 
Six Months Ended 
 June 30, 2018
 
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
 
Unrealized
Gains (Losses)
on Derivatives
 
Total
 
(In thousands)
$
 i 29,323

 
$
 i 305

 
$
 i 29,628

OCI before reclassifications
( i 63,292
)
 
 i 902

 
( i 62,390
)
Deferred income tax benefit (expense)
 i 13,289

 
( i 189
)
 
 i 13,100

AOCI before reclassifications, net of income tax
( i 20,680
)
 
 i 1,018

 
( i 19,662
)
Amounts reclassified from AOCI
 i 4,956

 
( i 55
)
 
 i 4,901

Deferred income tax benefit (expense)
( i 1,041
)
 
 i 12

 
( i 1,029
)
Amounts reclassified from AOCI, net of income tax
 i 3,915

 
( i 43
)
 
 i 3,872

Balance, June 30, 2018
$
( i 16,765
)
 
$
 i 975

 
$
( i 15,790
)
______________
(1)
See Note 4 for information on offsets to investments related to DAC and DSI.

34

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
7. Equity (continued)

 i 
Information regarding amounts reclassified out of each component of AOCI was as follows:
AOCI Components
 
Amounts Reclassified from AOCI
 
Statements of Operations and
Comprehensive Income (Loss) Locations
 
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
 
 
 
2019
 
2018
 
2019
 
2018
 
 
 
 
(In thousands)
 
 
Net unrealized investment gains (losses):
 
 
 
 
 
 
 
 
 
 
Net unrealized investment gains (losses)
 
$
 i 5,663

 
$
( i 2,123
)
 
$
 i 5,198

 
$
( i 4,962
)
 
Net investment gains (losses)
Net unrealized investment gains (losses)
 
 i 

 
 i 6

 
 i 

 
 i 6

 
Net investment income
Net unrealized investment gains (losses)
 
( i 8
)
 
 i 

 
( i 14
)
 
 i 

 
Net derivative gains (losses)
Net unrealized investment gains (losses), before income tax
 
 i 5,655

 
( i 2,117
)
 
 i 5,184

 
( i 4,956
)
 
 
Income tax (expense) benefit
 
( i 1,186
)
 
 i 445

 
( i 1,089
)
 
 i 1,041

 
 
Net unrealized investment gains (losses), net of income tax
 
 i 4,469

 
( i 1,672
)
 
 i 4,095

 
( i 3,915
)
 
 
Unrealized gains (losses) on derivatives - cash flow hedges:
 
 
 
 
 
 
 
 
 
 
Foreign currency swaps
 
 i 3

 
 i 49

 
 i 3

 
 i 55

 
Net derivative gains (losses)
Gains (losses) on cash flow hedges, before income tax
 
 i 3

 
 i 49

 
 i 3

 
 i 55

 
 
Income tax (expense) benefit
 
( i 1
)
 
( i 11
)
 
( i 1
)
 
( i 12
)
 
 
Gains (losses) on cash flow hedges, net of income tax
 
 i 2

 
 i 38

 
 i 2

 
 i 43

 
 
Total reclassifications, net of income tax
 
$
 i 4,471

 
$
( i 1,634
)
 
$
 i 4,097

 
$
( i 3,872
)
 
 

 / 
 i 
8. Other Revenues and Other Expenses
Other Revenues
The Company has entered into contracts with mutual funds, fund managers, and their affiliates (collectively, the “Funds”) whereby the Company is paid monthly or quarterly fees (“12b-1 fees”) for providing certain services to customers and distributors of the Funds. The 12b-1 fees are generally equal to a fixed percentage of the average daily balance of the customer’s investment in a fund. The percentage is specified in the contract between the Company and the Funds. Payments are generally collected when due and are neither refundable nor able to offset future fees.
To earn these fees, the Company performs services such as responding to phone inquiries, maintaining records, providing information to distributors and shareholders about fund performance and providing training to account managers and sales agents. The passage of time reflects the satisfaction of the Company’s performance obligations to the Funds and is used to recognize revenue associated with 12b-1 fees.
Other revenues consisted primarily of 12b-1 fees of $ i 3.2 million and $ i 6.3 million for the three months and six months ended June 30, 2019, respectively, and $ i 3.4 million and $ i 6.9 million for the three months and six months ended June 30, 2018, respectively, of which all were reported in the Annuities segment.

35

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
8. Other Revenues and Other Expenses (continued)

Other Expenses
 i 
Information on other expenses was as follows:
 
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
 
2019
 
2018
 
2019
 
2018
 
 
(In thousands)
Compensation
 
$
 i 4,771

 
$
 i 3,680

 
$
 i 9,440

 
$
 i 7,190

Contracted services and other labor costs
 
 i 3,439

 
 i 2,685

 
 i 6,036

 
 i 4,522

Transition services agreements
 
 i 3,743

 
 i 2,818

 
 i 7,527

 
 i 5,765

Establishment costs
 
 i 1,360

 
 i 

 
 i 2,841

 
 i 

Premium and other taxes, licenses and fees
 
( i 653
)
 
 i 742

 
 i 51

 
 i 1,785

Volume related costs, excluding compensation, net of DAC capitalization
 
 i 4,715

 
 i 4,546

 
 i 8,714

 
 i 9,810

Other
 
 i 2,249

 
 i 1,710

 
 i 3,905

 
 i 2,836

Total other expenses
 
$
 i 19,624

 
$
 i 16,181

 
$
 i 38,514

 
$
 i 31,908


 / 
Related Party Expenses
See Note 10 for a discussion of related party expenses included in the table above.
 i 
9. Contingencies, Commitments and Guarantees
Contingencies
Litigation
Sales Practices Claims
Over the past several years, the Company has faced claims and regulatory inquiries and investigations, alleging improper marketing or sales of individual life insurance policies, annuities, or other products. The Company continues to defend vigorously against the claims in these matters. The Company believes adequate provision has been made in its financial statements for all probable and reasonably estimable losses for sales practices matters.
Summary
Various litigation, claims and assessments against the Company, in addition to those discussed previously and those otherwise provided for in the Company’s financial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, investor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations.
It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to previously, large and/or indeterminate amounts, including punitive and treble damages, are sought. Although, in light of these considerations it is possible that an adverse outcome in certain cases could have a material effect upon the Company’s financial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company’s net income or cash flows in particular quarterly or annual periods.
Commitments
Mortgage Loan Commitments
The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $ i 15.1 million and $ i 7.6 million at June 30, 2019 and December 31, 2018, respectively.

36

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
9. Contingencies, Commitments and Guarantees (continued)

Commitments to Fund Private Corporate Bond Investments
The Company commits to lend funds under private corporate bond investments. The amounts of these unfunded commitments were $ i 2.7 million and $ i 11.4 million at June 30, 2019 and December 31, 2018, respectively.
Guarantees
In the normal course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties such that it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other specific liabilities and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemnifications to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third-party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation, while in other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future. Management believes that it is unlikely the Company will have to make any material payments under these indemnities, guarantees, or commitments.
In addition, the Company indemnifies its directors and officers as provided in its charters and by-laws. Also, the Company indemnifies its agents for liabilities incurred as a result of their representation of the Company’s interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these indemnities in the future.
The Company had  i no liability for indemnities, guarantees and commitments at both June 30, 2019 and December 31, 2018.
 i 
10. Related Party Transactions
The Company has various existing arrangements with its Brighthouse affiliates and had previous arrangements with MetLife for services necessary to conduct its activities. Certain of the MetLife services have continued, however, MetLife was no longer considered a related party upon the completion of the MetLife Divestiture on June 14, 2018 (see Note 1). The Company has related party investment and equity transactions (see Notes 4 and 7). Other material arrangements between the Company and its related parties not disclosed elsewhere are as follows:
Reinsurance Agreements
The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth.

37

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
10. Related Party Transactions (continued)

 i 
Information regarding the significant effects of related party reinsurance included on the interim condensed statements of operations and comprehensive income (loss) was as follows:
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2019
 
2018
 
2019
 
2018
 
(In thousands)
Premiums
 
 
 
 
 
 
 
Reinsurance ceded
$
( i 10,776
)
 
$
( i 9,614
)
 
$
( i 20,986
)
 
$
( i 17,726
)
Universal life and investment-type product policy fees
 
 
 
 
 
 
 
Reinsurance ceded
$
( i 990
)
 
$
( i 873
)
 
$
( i 1,793
)
 
$
( i 1,916
)
Other revenues
 
 
 
 
 
 
 
Reinsurance ceded
$
( i 24,998
)
 
$
( i 15,490
)
 
$
( i 48,506
)
 
$
( i 31,426
)
Policyholder benefits and claims
 
 
 
 
 
 
 
Reinsurance ceded
$
( i 17,745
)
 
$
( i 21,762
)
 
$
( i 25,958
)
 
$
( i 46,494
)
Information regarding the significant effects of ceded related party reinsurance included on the interim condensed balance sheets was as follows at:
 
 
 
(In thousands)
Assets
 
 
 
Premiums, reinsurance and other receivables
$
 i 575,642

 
$
 i 534,487

Liabilities
 
 
 
Other liabilities
$
 i 423,852

 
$
 i 429,656


 / 
The Company cedes risks to Brighthouse Life Insurance Company related to guaranteed minimum benefit guarantees written directly by the Company. These ceded reinsurance agreements contain embedded derivatives and changes in the estimated fair value are included within net derivative gains (losses). The embedded derivatives associated with the cessions are included within premiums, reinsurance and other receivables and were $ i 330.4 million and $ i 298.1 million at June 30, 2019 and December 31, 2018, respectively. Net derivative gains (losses) associated with the embedded derivatives were $ i 34.8 million and $ i 31.4 million for the three months and six months ended June 30, 2019, respectively, and ($ i 25.6) million and ($ i 71.4) million for the three months and six months ended June 30, 2018, respectively.
Shared Services and Overhead Allocations
Brighthouse affiliates currently provide and previously MetLife provided the Company certain services, which include, but are not limited to, treasury, financial planning and analysis, legal, human resources, tax planning, internal audit, financial reporting and information technology. Costs incurred under these arrangements with Brighthouse affiliates, as well as with MetLife prior to the MetLife Divestiture, were $ i 15.2 million and $ i 30.3 million for the three months and six months ended June 30, 2019, respectively, and $ i 10.1 million and $ i 19.8 million for the three months and six months ended June 30, 2018, respectively, and were recorded in other expenses. Revenues received from affiliates related to these agreements, recorded in universal life and investment-type product policy fees, were $ i 2.9 million and $ i 5.8 million for the three months and six months ended June 30, 2019, respectively, and $ i 3.1 million and $ i 6.3 million for the three months and six months ended June 30, 2018, respectively.
The Company had net receivables (payables) from/to affiliates, related to the items discussed above, of ($ i 6.6) million and $ i 622 thousand at June 30, 2019 and December 31, 2018, respectively.

38

Table of Contents
Brighthouse Life Insurance Company of NY
(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)
Notes to the Interim Condensed Financial Statements (Unaudited) (continued)
10. Related Party Transactions (continued)

Brighthouse affiliates incur costs related to the establishment of services and infrastructure to replace those previously provided by MetLife. The Company is charged a fee to reflect the value of the available infrastructure and services provided by these costs. While management believes the method used to allocate expenses under this arrangement is reasonable, the allocated expenses may not be indicative of those of a stand-alone entity. If expenses were allocated to the Company under this arrangement as incurred by Brighthouse affiliates, the Company would not have incurred additional expenses for the three months and six months ended June 30, 2019. The Company would have incurred additional expenses of $ i 2.2 million and $ i 4.1 million under this arrangement for the three months and six months ended June 30, 2018, respectively.
Broker-Dealer Transactions
The related party expense for the Company was commissions paid on the sale of variable products and passed through to the broker-dealer affiliate. The related party revenue for the Company was fee income passed through the broker-dealer affiliate from trusts and mutual funds whose shares serve as investment options of policyholders of the Company. Fee income received related to these transactions and recorded in other revenues was $ i 2.9 million and $ i 5.8 million for the three months and six months ended June 30, 2019, respectively, and $ i 3.1 million and $ i 6.3 million for the three months and six months ended June 30, 2018, respectively. Commission expenses incurred related to these transactions and recorded in other expenses was $ i 17.0 million and $ i 31.7 million for the three months and six months ended June 30, 2019, respectively, and $ i 12.2 million and $ i 25.3 million for the three months and six months ended June 30, 2018, respectively. The Company also had related party fee income receivables of $ i 962 thousand and $ i 951 thousand at June 30, 2019 and December 31, 2018, respectively.

39

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
Page

40

Table of Contents

Introduction
For purposes of this discussion, unless otherwise mentioned or unless the context indicates otherwise, “BHNY,” the “Company,” “we,” “our” and “us” refer to Brighthouse Life Insurance Company of NY (formerly, First MetLife Investors Insurance Company), a New York domiciled life insurance company. BHNY is an indirect wholly-owned subsidiary of Brighthouse Financial, Inc. (together with its subsidiaries and affiliates, “Brighthouse”). Management’s narrative analysis of the results of operations is presented pursuant to General Instruction H(2)(a) of Form 10-Q. This narrative analysis should be read in conjunction with (i) the unaudited interim condensed financial statements and related notes included elsewhere herein; (ii) our Annual Report on Form 10-K for the year ended December 31, 2018, filed with the U.S. Securities and Exchange Commission (“SEC”) on March 6, 2019 (the “2018 Annual Report”); (iii) our Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 (the “First Quarter Form 10-Q”) filed with the SEC on May 9, 2019; and (iv) our current reports on Form 8-K filed in 2019.
The term “Separation” refers to the separation of MetLife, Inc.’s (together with its subsidiaries and affiliates, “MetLife”) former Brighthouse Financial segment from MetLife’s other businesses and the creation of a separate, publicly traded company, Brighthouse Financial, Inc. (we use the term “BHF” to refer solely to Brighthouse Financial, Inc., and not to any of its subsidiaries), as well as the distribution on August 4, 2017 of 96,776,670, or 80.8%, of the 119,773,106 shares of BHF common stock outstanding immediately prior to the distribution date by MetLife, Inc. to holders of MetLife, Inc. common stock as of the record date for the distribution. The term “MetLife Divestiture” refers to the disposition by MetLife, Inc. on June 14, 2018 of all its remaining shares of BHF common stock. Effective with the MetLife Divestiture, MetLife, Inc. and its subsidiaries and affiliates are no longer considered related parties to Brighthouse Financial, Inc. and its subsidiaries and affiliates.
Overview
We offer a range of individual annuities and individual life insurance products in New York. For operating purposes, we have established two segments: Annuities and Life. In addition, we report certain of our results of operations in Corporate & Other. See “Business — Segments and Corporate & Other” included in the 2018 Annual Report along with Note 2 of the Notes to the Interim Condensed Financial Statements for further information on our segments and Corporate & Other.
See Note 1 of the Notes to the Interim Condensed Financial Statements for information regarding the adoption of new accounting pronouncements in 2019.
NAIC
The National Association of Insurance Commissioners (“NAIC”) is an organization, whose mission is to assist state insurance regulatory authorities in serving the public interest and achieving the insurance regulatory goals of its members, the state insurance regulatory officials. Through the NAIC, state insurance regulators establish standards and best practices, conduct peer reviews, and coordinate their regulatory oversight. The NAIC provides standardized insurance industry accounting and reporting guidance through its Accounting Practices and Procedures Manual (the “Manual”), which states have largely adopted by regulation. However, statutory accounting principles continue to be established by individual state laws, regulations and permitted practices, which may differ from the Manual. Changes to the Manual or modifications by the various states may impact our statutory capital and surplus.
The NAIC adopted a revised framework for statutory accounting, reserve and capital requirements for variable annuities in August 2018. The framework is designed to mitigate the motivation for insurers to engage in captive reinsurance transactions by making improvements to Actuarial Guideline 43 (“AG 43”) and the Life Risk Based Capital C3 Phase II (“RBC C3 Phase II”) capital requirements. The changes to AG 43 and RBC C3 Phase II are intended to (i) mitigate the asset-liability accounting mismatch between hedge instruments and statutory instruments and statutory liabilities, (ii) remove the non-economic volatility in statutory capital charges and the resulting solvency ratios and (iii) facilitate greater harmonization across insurers and their products for greater comparability. On August 6, 2019, the NAIC adopted changes to AG 43 and submitted the RBC C3 Phase II changes for NAIC Executive Committee and Plenary consent (which will be adopted after 10 days, unless otherwise objected to in accordance with the NAIC bylaws). The changes will become effective as of January 1, 2020, with early adoption permitted as of December 31, 2019.
The adopted changes will apply to all of our existing variable annuity business and may materially change the sensitivity of reserve and capital requirements to capital markets including interest rate, equity markets and volatility, our estimates of which historically did not reflect the impact of variable annuity capital reform or changes in tax rates, as well as prescribed assumptions for policyholder behavior. We have not yet determined what impacts this reform will have on current risk mitigation and hedging programs. See “Risk Factors — Regulatory and Legal Risks — Our business is highly regulated, and changes in regulation and in supervisory and enforcement policies may materially impact our capitalization or cash flows, reduce our profitability and limit our growth” in our 2018 Annual Report.

41

Table of Contents

In addition, following the reduction in the statutory tax rate pursuant to the Tax Cuts and Jobs Act (the “Tax Act”), the NAIC reviewed the methodology by which taxes are incorporated into the risk-based capital (“RBC”) calculation. On August 7, 2018 the NAIC Executive Committee and Plenary, a body comprised of all U.S. state insurance commissioners and the NAIC Executive Committee, adopted changes to the RBC calculation effective December 31, 2018 to reflect the lower statutory tax rate, which resulted in a reduction to our insurance subsidiaries’ RBC ratios. As of the date of the most recent annual statutory financial statements filed with insurance regulators, the total adjusted capital of each of our insurance subsidiaries was in excess of RBC levels required by regulators.
The NAIC has adopted a new approach for the calculation of life insurance reserves, known as principle-based reserving (“PBR”). PBR became operative on January 1, 2017 in those states where it has been adopted, to be followed by a three-year phase-in period for business issued on or after this date. With respect to the states in which our insurance subsidiaries are domiciled, the Delaware Department of Insurance implemented PBR on January 1, 2017, and New York enacted legislation adopting PBR in December 2018. At the same time, the New York Department of Financial Services adopted a temporary regulation to implement PBR while it develops a final regulation. PBR legislation was signed into law in Massachusetts in January 2019. See “Risk Factors — Regulatory and Legal Risks — Our business is highly regulated, and changes in regulation and in supervisory and enforcement policies may materially impact our capitalization or cash flows, reduce our profitability and limit our growth” in our 2018 Annual Report.
The NAIC is considering revisions to RBC factors for bonds and real estate, as well as developing RBC charges for longevity risk. We cannot predict the impact of any potential proposals that may result from these studies.
We can give no assurances that any of our expectations will be met regarding the capital and reserve impacts or compliance costs, if any, that may result from the above initiatives.
Standard of Conduct Regulation
As a result of overlapping efforts by the Department of Labor, the NAIC, individual states, and the SEC to impose fiduciary-like requirements in connection with the sale of annuities, life insurance policies and securities, which are each discussed in more detail below, there have been a number of proposed or adopted changes to the laws and regulations that govern the conduct of our business and the firms that distribute our products. As a manufacturer of annuity and life insurance products, we do not directly distribute our products to consumers. However, regulations establishing standards of conduct in connection with the distribution and sale of these products could affect our business by imposing greater compliance, oversight, disclosure and notification requirements on our distributors and/or us, which may in either case increase our costs or limit distribution of our products. We cannot predict what other proposals may be made, what legislation or regulations may be introduced or enacted, or what impact any future legislation or regulations may have on our business, results of operations and financial condition. See “Risk Factors — Regulatory and Legal Risks — Our business is highly regulated, and changes in regulation and in supervisory and enforcement policies may materially impact our capitalization or cash flows, reduce our profitability and limit our growth — Standard of Conduct Regulation” in our 2018 Annual Report.
New SEC Rules Addressing Standards of Conduct for Broker-Dealers
On June 5, 2019, the SEC adopted a comprehensive set of rules and interpretations for broker-dealers and investment advisers, including new Regulation Best Interest. Among other things, the package of new regulations (i) requires broker-dealers to act in the best interest of their retail clients without placing their own interests ahead of those of their clients when providing securities recommendations or advice; (ii) clarifies the nature of the fiduciary obligations owed by registered investment advisers to their clients; (iii) imposes new disclosure requirements on broker-dealers and investment advisers aimed at ensuring investors understand the nature of their relationship with their investment professionals and, in the case of broker-dealers, disclosing all material facts about conflicts of interest; and (iv) restricts broker-dealers and their financial professionals from using certain compensation practices and the terms “adviser” or “advisor.” The intent of Regulation Best Interest is to impose an enhanced standard of care on broker-dealers which is more similar to that of an investment adviser. Among other things, this would require broker-dealers to mitigate conflicts of interest arising from financial incentives in selling securities products.
Regulation Best Interest may change the way broker-dealers sell securities such as variable annuities to their customers. Moreover, it may impact broker-dealer sales of other annuity products that are not securities because it could be difficult for broker-dealers to differentiate their sales practices. Per the timeline established by the SEC, broker-dealers will be required to comply with the requirements of Regulation Best Interest beginning June 30, 2020. Given the complexity of this package of regulations and the fact that it was just recently adopted, its likely impact on the distribution of our products is uncertain. It is also unclear whether Regulation Best Interest will have any preemptive effect on similar existing or forthcoming state-level standard of conduct regulations.


42

Table of Contents

Summary of Critical Accounting Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the Interim Condensed Financial Statements.
The most critical estimates include those used in determining: 
(i)
liabilities for future policy benefits;
(ii)
accounting for reinsurance;
(iii)
capitalization and amortization of deferred policy acquisition costs (“DAC”) and amortization of value of business acquired (“VOBA”);
(iv)
estimated fair values of investments in the absence of quoted market values;
(v)
investment impairments;
(vi)
estimated fair values of freestanding derivatives and the recognition and estimated fair value of embedded derivatives requiring bifurcation;
(vii)
measurement of income taxes and the valuation of deferred tax assets; and
(viii)
liabilities for litigation and regulatory matters.
In applying our accounting policies, we make subjective and complex judgments that frequently require estimates about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to our business and operations. Actual results could differ from these estimates.
The above critical accounting estimates are described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Summary of Critical Accounting Estimates” and Note 1 of the Notes to the Financial Statements included in the 2018 Annual Report.
Non-GAAP and Other Financial Disclosures
Our definitions of the non-GAAP and other financial measures may differ from those used by other companies.
Non-GAAP Financial Disclosures
Adjusted Earnings
In this report, we present adjusted earnings as a measure of our performance that is not calculated in accordance with GAAP. We believe that this non-GAAP financial measure highlights our results of operations and the underlying profitability drivers of our business, as well as enhances the understanding of our performance by the investor community. However, adjusted earnings should not be viewed as a substitute for net income (loss), which is the most directly comparable financial measure calculated in accordance with GAAP. See “— Results of Operations” for a reconciliation of adjusted earnings to net income (loss).
Adjusted earnings, which may be positive or negative, is used by management to evaluate performance, allocate resources and facilitate comparisons to industry results. This financial measure focuses on our primary businesses principally by excluding the impact of market volatility, which could distort trends.
The following are significant items excluded from total revenues, net of income tax, in calculating adjusted earnings:
Net investment gains (losses);
Net derivative gains (losses) except earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment (“Investment Hedge Adjustments”); and
Certain variable annuity guaranteed minimum income benefits (“GMIBs”) fees (“GMIB Fees”) and amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses).
The following are significant items excluded from total expenses, net of income tax, in calculating adjusted earnings:

43

Table of Contents

Amounts associated with benefits and hedging costs related to GMIBs (“GMIB Costs”);
Amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”); and
Amortization of DAC and VOBA related to (i) net investment gains (losses), (ii) net derivative gains (losses), (iii) GMIB Fees and GMIB Costs and (iv) Market Value Adjustments.
The tax impact of the adjustments mentioned is calculated net of the statutory tax rate, which could differ from our effective tax rate.
We present adjusted earnings in a manner consistent with management’s view of the primary business activities that drive the profitability of our core businesses. The following table illustrates how each component of adjusted earnings is calculated from the GAAP statement of operations line items:
Component of Adjusted Earnings
How Derived from GAAP (1)
(i)
Fee income
(i)
Universal life and investment-type policy fees (excluding (a) unearned revenue adjustments related to net investment gains (losses) and net derivative gains (losses) and (b) GMIB Fees) plus Other revenues (excluding other revenues associated with related party reinsurance) and amortization of deferred gain on reinsurance.
(ii)
Net investment spread
(ii)
Net investment income plus Investment Hedge Adjustments and interest received on ceded fixed annuity reinsurance deposit funds reduced by Interest credited to policyholder account balances and interest on future policy benefits.
(iii)
Insurance-related activities
(iii)
Premiums less Policyholder benefits and claims (excluding (a) GMIB Costs, (b) Market Value Adjustments, (c) interest on future policy benefits and (d) amortization of deferred gain on reinsurance) plus the pass through of performance of ceded separate account assets.
(iv)
Amortization of DAC and VOBA
(iv)
Amortization of DAC and VOBA (excluding amounts related to (a) net investment gains (losses), (b) net derivative gains (losses), (c) GMIB Fees and GMIB Costs and (d) Market Value Adjustments).
(v)
Other expenses, net of DAC capitalization
(v)
Other expenses reduced by capitalization of DAC.
(vi)
Provision for income tax expense (benefit)
(vi)
Tax impact of the above items.
______________
(1)
Italicized items indicate GAAP statement of operations line items.
Consistent with GAAP guidance for segment reporting, adjusted earnings is also our GAAP measure of segment performance. Accordingly, we report adjusted earnings by segment in Note 2 of the Notes to the Interim Condensed Financial Statements.
Other Financial Disclosures
We sometimes refer to sales activity for various products. Statistical sales information for life sales are calculated using the LIMRA (Life Insurance Marketing and Research Association) definition of sales for core direct sales, excluding company-sponsored internal exchanges, corporate-owned life insurance, bank-owned life insurance, and private placement variable universal life insurance. Annuity sales consist of 10% of direct statutory premiums, excluding company-sponsored internal exchanges. These sales statistics do not correspond to revenues under GAAP, but are used as relevant measures of business activity.

44

Table of Contents

Results of Operations
Results for the Six Months Ended June 30, 2019 and 2018
Business Overview. Annuity sales increased 42% for the six months ended June 30, 2019, compared to the six months ended June 30, 2018. This increase resulted primarily from sales of our structured annuities consisting of products marketed under various names (collectively, “Shield Annuities”).
A significant portion of our net income is driven by separate account balances, related to our variable annuity business. Most directly, these balances determine asset-based fee income, but they also impact DAC amortization and asset-based commissions. Separate account balances are driven by sales, movements in the market, surrenders, withdrawals, benefit payments, transfers and policy charges. Variable annuities separate account balances increased for the six months ended June 30, 2019, compared to December 31, 2018, driven by positive equity market performance, partially offset by negative net flows and policy charges.
Unless otherwise noted, all amounts in the following discussions of our results of operations are stated before income tax except for adjusted earnings, which are presented net of income tax.
 
 
Six Months Ended 
 June 30,
 
 
2019
 
2018
 
 
(In thousands)
Revenues
 
 
 
 
Premiums
 
$
15,998

 
$
19,405

Universal life and investment-type product policy fees
 
47,393

 
51,869

Net investment income
 
56,209

 
48,020

Other revenues
 
(42,031
)
 
(24,620
)
Net investment gains (losses)
 
5,020

 
(4,418
)
Net derivative gains (losses)
 
24,063

 
(65,374
)
Total revenues
 
106,652

 
24,882

Expenses
 
 
 
 
Policyholder benefits and claims
 
23,847

 
2,407

Interest credited to policyholder account balances
 
17,391

 
18,569

Capitalization of DAC
 
(18,451
)
 
(14,407
)
Amortization of DAC and VOBA
 
6,463

 
(1,828
)
Other expenses
 
56,965

 
46,315

Total expenses
 
86,215

 
51,056

Income (loss) before provision for income tax
 
20,437

 
(26,174
)
Provision for income tax expense (benefit)
 
2,961

 
(6,843
)
Net income (loss)
 
$
17,476

 
$
(19,331
)

45

Table of Contents

The table below shows the components of net income (loss).
 
 
Six Months Ended 
 June 30,
 
 
2019
 
2018
 
 
(In thousands)
GMLB Riders
 
$
44,454

 
$
(45,208
)
Other derivative instruments
 
(5,504
)
 
(3,924
)
Net investment gains (losses)
 
5,020

 
(4,418
)
Other adjustments
 
304

 
455

Pre-tax adjusted earnings
 
(23,837
)
 
26,921

Income (loss) before provision for income tax
 
20,437

 
(26,174
)
Provision for income tax expense (benefit)
 
2,961

 
(6,843
)
Net income (loss)
 
$
17,476

 
$
(19,331
)
Six Months Ended June 30, 2019 Compared with the Six Months Ended June 30, 2018
Net income before provision for income tax was $20.4 million ($17.5 million, net of income tax), an increase of $46.6 million ($36.8 million, net of income tax) from a loss before provision for income tax of $26.2 million ($19.3 million, net of income tax) in the prior period.
The improvement in income before provision for income tax was primarily due to:
net favorable changes in guaranteed minimum living benefits (“GMLB”) Riders driven by:
gains on the fair value of our ceded variable annuity riders, primarily driven by lower interest rates, net of the impact of higher equity markets
partially offset by
losses on the fair value of the Shield Annuities as the positive equity markets in the current period had an unfavorable impact on the embedded derivative liabilities which exceeded the favorable impact to the equity indexed options hedging the liabilities, and
higher net investment gains reflecting gains on the sale of fixed maturities in the current period compared to net losses on the sale of fixed maturity securities in the prior period.
The decrease in the loss before provision for income tax was partially offset by lower adjusted earnings discussed in greater detail below.
The provision for income tax in the current period led to an effective tax rate of 14%, compared to 26% in the prior period. Our effective tax rate primarily differs from the statutory tax rate due to the impacts of the dividends received deductions and tax credits.
Reconciliation of Net Income (Loss) to Adjusted Earnings
 
 
Six Months Ended 
 June 30,
 
 
2019
 
2018
 
 
(In thousands)
Net income (loss)
 
$
17,476

 
$
(19,331
)
Add: Provision for income tax expense (benefit)
 
2,961

 
(6,843
)
Income (loss) before provision for income tax
 
20,437

 
(26,174
)
Less: GMLB Riders
 
44,454

 
(45,208
)
Less: Other derivative instruments
 
(5,504
)
 
(3,924
)
Less: Net investment gains (losses)
 
5,020

 
(4,418
)
Less: Other adjustments
 
304

 
455

Pre-tax adjusted earnings
 
(23,837
)
 
26,921

Less: Provision for income tax expense (benefit)
 
(6,336
)
 
4,306

Adjusted earnings
 
$
(17,501
)
 
$
22,615


46

Table of Contents

Results for the Six Months Ended June 30, 2019 and 2018 Adjusted Earnings
The following table presents the components of adjusted earnings:
 
 
Six Months Ended 
 June 30,
 
 
2019
 
2018
 
 
(In thousands)
Fee income
 
$
67,100

 
$
74,758

Net investment spread
 
29,780

 
20,535

Insurance-related activities
 
(64,467
)
 
(21,584
)
Amortization of DAC and VOBA
 
(17,736
)
 
(14,880
)
Other expenses, net of DAC capitalization
 
(38,514
)
 
(31,908
)
Pre-tax adjusted earnings
 
(23,837
)
 
26,921

Provision for income tax expense (benefit)
 
(6,336
)
 
4,306

Adjusted earnings
 
$
(17,501
)
 
$
22,615

Six Months Ended June 30, 2019 Compared with the Six Months Ended June 30, 2018
Adjusted earnings were a loss of $17.5 million, a decrease of $40.1 million.
Key net unfavorable impacts were:
higher costs associated with insurance-related activities due to:
higher reserves in the current period on yearly renewable term business reinsured to an affiliate, and
unfavorable change in the fair value of the underlying ceded separate account assets under a related party reinsurance agreement for certain variable annuity contracts;
lower fee income due to lower asset-based fees resulting from lower average separate account balances; and
higher other expenses due to an increase in the allocation of corporate expenses.
The decrease in adjusted earnings was partially offset by higher net investment spread, reflecting higher average invested assets resulting from positive net flows in the general account.
The provision for income tax in the current period led to an effective tax rate of 27%, compared to 16% in the prior period. Our effective tax rate primarily differs from the statutory tax rate due to the impacts of the dividends received deductions and tax credits.

47

Table of Contents

Note Regarding Forward-Looking Statements
This report, including Management’s Discussion and Analysis of Financial Condition and Results of Operations, and other oral or written statements that we make from time to time may contain information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve substantial risks and uncertainties. We have tried, wherever possible, to identify such statements using words such as “anticipate,” “estimate,” “expect,” “project,” “may,” “will,” “could,” “intend,” “goal,” “target,” “guidance,” “forecast,” “preliminary,” “objective,” “continue,” “aim,” “plan,” “believe” and other words and terms of similar meaning, or that are tied to future periods, in connection with a discussion of future operating or financial performance. In particular, these include, without limitation, statements relating to future actions, prospective services or products, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, trends in operating and financial results, as well as statements regarding the expected benefits of the Separation.
Any or all forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining the actual future results of BHNY. These statements are based on current expectations and the current economic environment and involve a number of risks and uncertainties that are difficult to predict. These statements are not guarantees of future performance. Actual results could differ materially from those expressed or implied in the forward-looking statements due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others:
differences between actual experience and actuarial assumptions and the effectiveness of our actuarial models;
higher risk management costs and exposure to increased market and counterparty risk due to guarantees within certain of our products;
the potential material adverse effect of changes in accounting standards, practices and/or policies applicable to us including changes in the accounting for long-duration contracts;
the effect adverse capital and credit market conditions may have on our ability to meet liquidity needs and our access to capital;
the impact of changes in regulation and in supervisory and enforcement policies on our insurance business or other operations;
the effectiveness of our risk management policies and procedures;
the availability of reinsurance and the ability of our counterparties to our reinsurance or indemnification arrangements to perform their obligations thereunder;
heightened competition, including with respect to service, product features, scale, price, actual or perceived financial strength, claims-paying ratings, financial strength ratings, e-business capabilities and name recognition;
our ability to market and distribute our products through distribution channels;
any failure of third parties to provide services we need, any failure of the practices and procedures of these third parties and any inability to obtain information or assistance we need from third parties, including MetLife;
whether all or any portion of the tax consequences of the Separation are not as expected, leading to material additional taxes or material adverse consequences to tax attributes that impact us;
the uncertainty of the outcome of any disputes with MetLife over tax-related or other matters and agreements, including the potential of outcomes adverse to us that could cause us to owe MetLife material tax reimbursements or payments, or disagreements regarding MetLife’s or our obligations under our other agreements;
the impact on our business structure, profitability, cost of capital and flexibility due to restrictions we have agreed to that preserve the tax-free treatment of certain parts of the Separation;
the potential material negative tax impact of potential future tax legislation that could decrease the value of our tax attributes and cause other cash expenses, such as reserves, to increase materially and make some of our products less attractive to consumers;
whether the Separation will qualify for non-recognition treatment for federal income tax purposes and potential indemnification to MetLife if the Separation does not so qualify;

48

Table of Contents

the impact of the Separation on our business and profitability due to MetLife’s strong brand and reputation, the increased costs related to replacing arrangements with MetLife with those of third parties and incremental costs as a public company;
whether the operational, strategic and other benefits of the Separation can be achieved, and our ability to implement our business strategy;
our ability to attract and retain key personnel; and
other factors described in our 2018 Annual Report, our subsequent Quarterly Reports on Form 10-Q, and from time to time in documents that we file with the SEC.
For the reasons described above, we caution you against relying on any forward-looking statements, which should also be read in conjunction with the other cautionary statements included and the risks, uncertainties and other factors identified in our 2018 Annual Report, our subsequent Quarterly Reports on Form 10-Q, particularly in the sections entitled “Risk Factors” and “Quantitative and Qualitative Disclosures About Market Risk,” as well as in our other subsequent SEC filings. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as otherwise may be required by law.
Item 4. Controls and Procedures
Management, with the participation of the Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”), as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures were effective as of June 30, 2019.
MetLife provides certain services to the Company on a transitional basis through services agreements. The Company continues to change business processes, implement systems and establish new third-party arrangements, as a subsidiary of Brighthouse Financial, Inc. We consider these to be material changes in our internal control over financial reporting.
Other than as noted above, there were no changes to the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended June 30, 2019 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Part II — Other Information
Item 1. Legal Proceedings
See Note 9 of the Notes to the Interim Condensed Financial Statements included in this report. There have been no new material legal proceedings and no material developments in legal proceedings previously disclosed in the 2018 Annual Report.
Item 1A. Risk Factors
We discuss in this report, in the 2018 Annual Report and in our other filings with the SEC, various risks that may materially affect our business. In addition, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Note Regarding Forward-Looking Statements” included in this report. There have been no material changes to our risk factors from the risk factors previously disclosed in the 2018 Annual Report, as amended or supplemented by such information in our subsequent Quarterly Reports on Form 10-Q.

49

Table of Contents

Item 6. Exhibits
(Note Regarding Reliance on Statements in Our Contracts: In reviewing the agreements included as exhibits herein, please remember that they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about Brighthouse Life Insurance Company of NY, its affiliates, or the other parties to the agreements. The agreements contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other parties to the applicable agreement and (i) should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate; (ii) have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement; (iii) may apply standards of materiality in a way that is different from what may be viewed as material to investors; and (iv) were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments. Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time. Additional information about Brighthouse Life Insurance Company of NY may be found elsewhere herein and Brighthouse Life Insurance Company of NY’s other public filings, which are available without charge through the U.S. Securities and Exchange Commission website at www.sec.gov.)
Exhibit
No.
 
Description
10.1*
 
31.1*
 
31.2*
 
32.1**
 
32.2**
 
101.INS*
 
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*
 
Inline XBRL Taxonomy Extension Schema Document.
101.CAL*
 
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB*
 
Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*
 
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF*
 
Inline XBRL Taxonomy Extension Definition Linkbase Document.
104*
 
The cover page of Brighthouse Life Insurance Company of NY’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2019, formatted in Inline XBRL (included within the Exhibit 101 attachments).
* Filed herewith.
** Furnished herewith.


50

Table of Contents

Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY
 
 
 
By:
 
 
 
Name:
 
 
Title:
 
Vice President and Chief Financial Officer
 
 
 
(Authorized Signatory and Principal Financial Officer)
Date: August 8, 2019

51

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
1/1/22
1/1/21
6/30/2010-Q
1/1/20
12/31/1910-K
Filed on:8/8/19
8/6/19
7/17/19
For Period end:6/30/19
6/5/19
5/9/1910-Q
3/31/1910-Q
3/6/1910-K
1/1/19
12/31/1810-K
8/7/18
6/30/1810-Q
6/14/18
3/31/1810-Q
12/31/1710-K
8/4/178-K
1/1/17
 List all Filings 
Top
Filing Submission 0001167609-19-000011   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 4:53:29.1pm ET